
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene RAD51C - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="ABCBAA3892650C533DAA38003F375014.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cancers">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9221245/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cancers">
<meta name="citation_title" content="Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene RAD51C">
<meta name="citation_author" content="Lara Sanoguera-Miralles">
<meta name="citation_author_institution" content="Splicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC-UVa), 47003 Valladolid, Spain; lara.sanoguera@uva.es (L.S.-M.); elena.bueno@uva.es (E.B.-M.); alberto.valenzuela@ibgm.uva.es (A.V.-P.); ines.llinares@alumnos.uva.es (I.L.-B.); aliciaga@ibgm.uva.es (A.G.-Á.)">
<meta name="citation_author" content="Elena Bueno-Martínez">
<meta name="citation_author_institution" content="Splicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC-UVa), 47003 Valladolid, Spain; lara.sanoguera@uva.es (L.S.-M.); elena.bueno@uva.es (E.B.-M.); alberto.valenzuela@ibgm.uva.es (A.V.-P.); ines.llinares@alumnos.uva.es (I.L.-B.); aliciaga@ibgm.uva.es (A.G.-Á.)">
<meta name="citation_author" content="Alberto Valenzuela-Palomo">
<meta name="citation_author_institution" content="Splicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC-UVa), 47003 Valladolid, Spain; lara.sanoguera@uva.es (L.S.-M.); elena.bueno@uva.es (E.B.-M.); alberto.valenzuela@ibgm.uva.es (A.V.-P.); ines.llinares@alumnos.uva.es (I.L.-B.); aliciaga@ibgm.uva.es (A.G.-Á.)">
<meta name="citation_author" content="Ada Esteban-Sánchez">
<meta name="citation_author_institution" content="Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), 28040 Madrid, Spain; ada.esteban@salud.madrid.org (A.E.-S.); pedro.perez@salud.madrid.org (P.P.-S.); miguel.hoya@salud.madrid.org (M.d.l.H.)">
<meta name="citation_author" content="Inés Llinares-Burguet">
<meta name="citation_author_institution" content="Splicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC-UVa), 47003 Valladolid, Spain; lara.sanoguera@uva.es (L.S.-M.); elena.bueno@uva.es (E.B.-M.); alberto.valenzuela@ibgm.uva.es (A.V.-P.); ines.llinares@alumnos.uva.es (I.L.-B.); aliciaga@ibgm.uva.es (A.G.-Á.)">
<meta name="citation_author" content="Pedro Pérez-Segura">
<meta name="citation_author_institution" content="Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), 28040 Madrid, Spain; ada.esteban@salud.madrid.org (A.E.-S.); pedro.perez@salud.madrid.org (P.P.-S.); miguel.hoya@salud.madrid.org (M.d.l.H.)">
<meta name="citation_author" content="Alicia García-Álvarez">
<meta name="citation_author_institution" content="Splicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC-UVa), 47003 Valladolid, Spain; lara.sanoguera@uva.es (L.S.-M.); elena.bueno@uva.es (E.B.-M.); alberto.valenzuela@ibgm.uva.es (A.V.-P.); ines.llinares@alumnos.uva.es (I.L.-B.); aliciaga@ibgm.uva.es (A.G.-Á.)">
<meta name="citation_author" content="Miguel de la Hoya">
<meta name="citation_author_institution" content="Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), 28040 Madrid, Spain; ada.esteban@salud.madrid.org (A.E.-S.); pedro.perez@salud.madrid.org (P.P.-S.); miguel.hoya@salud.madrid.org (M.d.l.H.)">
<meta name="citation_author" content="Eladio A Velasco-Sampedro">
<meta name="citation_author_institution" content="Splicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC-UVa), 47003 Valladolid, Spain; lara.sanoguera@uva.es (L.S.-M.); elena.bueno@uva.es (E.B.-M.); alberto.valenzuela@ibgm.uva.es (A.V.-P.); ines.llinares@alumnos.uva.es (I.L.-B.); aliciaga@ibgm.uva.es (A.G.-Á.)">
<meta name="citation_publication_date" content="2022 Jun 15">
<meta name="citation_volume" content="14">
<meta name="citation_issue" content="12">
<meta name="citation_firstpage" content="2960">
<meta name="citation_doi" content="10.3390/cancers14122960">
<meta name="citation_pmid" content="35740625">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9221245/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9221245/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9221245/pdf/cancers-14-02960.pdf">
<meta name="description" content="Loss-of-function variants of the RAD51C gene are known to confer a risk of breast and ovarian cancers. In this study, we analyzed the impact of RAD51C variants on splicing, a highly regulated gene expression step by which introns are removed and ...">
<meta name="og:title" content="Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene RAD51C">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Loss-of-function variants of the RAD51C gene are known to confer a risk of breast and ovarian cancers. In this study, we analyzed the impact of RAD51C variants on splicing, a highly regulated gene expression step by which introns are removed and ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9221245/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9221245">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/cancers14122960"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/cancers-14-02960.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9221245%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9221245/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9221245/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9221245/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cancers.png" alt="Cancers logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cancers" title="Link to Cancers" shape="default" href="http://www.mdpi.com/journal/cancers" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cancers (Basel)</button></div>. 2022 Jun 15;14(12):2960. doi: <a href="https://doi.org/10.3390/cancers14122960" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/cancers14122960</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Cancers%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cancers%20(Basel)%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cancers%20(Basel)%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cancers%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene <em>RAD51C</em>
</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sanoguera-Miralles%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Lara Sanoguera-Miralles</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Lara Sanoguera-Miralles</span></h3>
<div class="p">
<sup>1</sup>Splicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC-UVa), 47003 Valladolid, Spain; lara.sanoguera@uva.es (L.S.-M.); elena.bueno@uva.es (E.B.-M.); alberto.valenzuela@ibgm.uva.es (A.V.-P.); ines.llinares@alumnos.uva.es (I.L.-B.); aliciaga@ibgm.uva.es (A.G.-Á.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sanoguera-Miralles%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lara Sanoguera-Miralles</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bueno-Mart%C3%ADnez%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Elena Bueno-Martínez</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Elena Bueno-Martínez</span></h3>
<div class="p">
<sup>1</sup>Splicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC-UVa), 47003 Valladolid, Spain; lara.sanoguera@uva.es (L.S.-M.); elena.bueno@uva.es (E.B.-M.); alberto.valenzuela@ibgm.uva.es (A.V.-P.); ines.llinares@alumnos.uva.es (I.L.-B.); aliciaga@ibgm.uva.es (A.G.-Á.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bueno-Mart%C3%ADnez%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elena Bueno-Martínez</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Valenzuela-Palomo%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Alberto Valenzuela-Palomo</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Alberto Valenzuela-Palomo</span></h3>
<div class="p">
<sup>1</sup>Splicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC-UVa), 47003 Valladolid, Spain; lara.sanoguera@uva.es (L.S.-M.); elena.bueno@uva.es (E.B.-M.); alberto.valenzuela@ibgm.uva.es (A.V.-P.); ines.llinares@alumnos.uva.es (I.L.-B.); aliciaga@ibgm.uva.es (A.G.-Á.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Valenzuela-Palomo%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alberto Valenzuela-Palomo</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Esteban-S%C3%A1nchez%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ada Esteban-Sánchez</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ada Esteban-Sánchez</span></h3>
<div class="p">
<sup>2</sup>Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), 28040 Madrid, Spain; ada.esteban@salud.madrid.org (A.E.-S.); pedro.perez@salud.madrid.org (P.P.-S.); miguel.hoya@salud.madrid.org (M.d.l.H.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Esteban-S%C3%A1nchez%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ada Esteban-Sánchez</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Llinares-Burguet%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Inés Llinares-Burguet</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Inés Llinares-Burguet</span></h3>
<div class="p">
<sup>1</sup>Splicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC-UVa), 47003 Valladolid, Spain; lara.sanoguera@uva.es (L.S.-M.); elena.bueno@uva.es (E.B.-M.); alberto.valenzuela@ibgm.uva.es (A.V.-P.); ines.llinares@alumnos.uva.es (I.L.-B.); aliciaga@ibgm.uva.es (A.G.-Á.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Llinares-Burguet%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Inés Llinares-Burguet</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22P%C3%A9rez-Segura%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Pedro Pérez-Segura</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Pedro Pérez-Segura</span></h3>
<div class="p">
<sup>2</sup>Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), 28040 Madrid, Spain; ada.esteban@salud.madrid.org (A.E.-S.); pedro.perez@salud.madrid.org (P.P.-S.); miguel.hoya@salud.madrid.org (M.d.l.H.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22P%C3%A9rez-Segura%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Pedro Pérez-Segura</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Garc%C3%ADa-%C3%81lvarez%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Alicia García-Álvarez</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Alicia García-Álvarez</span></h3>
<div class="p">
<sup>1</sup>Splicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC-UVa), 47003 Valladolid, Spain; lara.sanoguera@uva.es (L.S.-M.); elena.bueno@uva.es (E.B.-M.); alberto.valenzuela@ibgm.uva.es (A.V.-P.); ines.llinares@alumnos.uva.es (I.L.-B.); aliciaga@ibgm.uva.es (A.G.-Á.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Garc%C3%ADa-%C3%81lvarez%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alicia García-Álvarez</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20la%20Hoya%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Miguel de la Hoya</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Miguel de la Hoya</span></h3>
<div class="p">
<sup>2</sup>Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), 28040 Madrid, Spain; ada.esteban@salud.madrid.org (A.E.-S.); pedro.perez@salud.madrid.org (P.P.-S.); miguel.hoya@salud.madrid.org (M.d.l.H.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22de%20la%20Hoya%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Miguel de la Hoya</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Velasco-Sampedro%20EA%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Eladio A Velasco-Sampedro</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Eladio A Velasco-Sampedro</span></h3>
<div class="p">
<sup>1</sup>Splicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC-UVa), 47003 Valladolid, Spain; lara.sanoguera@uva.es (L.S.-M.); elena.bueno@uva.es (E.B.-M.); alberto.valenzuela@ibgm.uva.es (A.V.-P.); ines.llinares@alumnos.uva.es (I.L.-B.); aliciaga@ibgm.uva.es (A.G.-Á.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Velasco-Sampedro%20EA%22%5BAuthor%5D" class="usa-link"><span class="name western">Eladio A Velasco-Sampedro</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">Christian Singer</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-cancers-14-02960">
<sup>1</sup>Splicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biología y Genética Molecular, Consejo Superior de Investigaciones Científicas (CSIC-UVa), 47003 Valladolid, Spain; lara.sanoguera@uva.es (L.S.-M.); elena.bueno@uva.es (E.B.-M.); alberto.valenzuela@ibgm.uva.es (A.V.-P.); ines.llinares@alumnos.uva.es (I.L.-B.); aliciaga@ibgm.uva.es (A.G.-Á.)</div>
<div id="af2-cancers-14-02960">
<sup>2</sup>Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), 28040 Madrid, Spain; ada.esteban@salud.madrid.org (A.E.-S.); pedro.perez@salud.madrid.org (P.P.-S.); miguel.hoya@salud.madrid.org (M.d.l.H.)</div>
<div class="author-notes p"><div class="fn" id="c1-cancers-14-02960">
<sup>*</sup><p class="display-inline">Correspondence: <span>eavelsam@ibgm.uva.es</span></p>
</div></div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Christian Singer</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2022 May 19; Accepted 2022 Jun 14; Collection date 2022 Jun.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2022 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9221245  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35740625/" class="usa-link">35740625</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Simple Summary</h3>
<p>Loss-of-function variants of the <em>RAD51C</em> gene are known to confer a risk of breast and ovarian cancers. In this study, we analyzed the impact of <em>RAD51C</em> variants on splicing, a highly regulated gene expression step by which introns are removed and exons are sequentially joined. Exon recognition is guided by specific sequences, the 3′ and 5′ splice sites, which define the exon boundaries. Variants of these sequences of susceptibility genes may lead to aberrant splicing and abnormal transcripts that may trigger a disease. Splicing can be tested using a biotechnological tool called minigenes, which mimic the human gene of interest. Thus, we checked 20 <em>RAD51C</em> splice-site variants using the minigene mgR51C_ex2-8. We found that they all disrupted the splicing mechanism, and 16 variants could be classified as likely pathogenic. Our findings are clinically actionable, and variant carriers may benefit from tailored prevention protocols and therapies.</p></section><section id="sec2"><h3 class="pmc_sec_title">Abstract</h3>
<p><em>RAD51C</em> loss-of-function variants are associated with an increased risk of breast and ovarian cancers. Likewise, splicing disruptions are a frequent mechanism of gene inactivation. Taking advantage of a previous splicing-reporter minigene with exons 2-8 (mgR51C_ex2-8), we proceeded to check its impact on the splicing of candidate ClinVar variants. A total of 141 <em>RAD51C</em> variants at the intron/exon boundaries were analyzed with MaxEntScan. Twenty variants were selected and genetically engineered into the wild-type minigene. All the variants disrupted splicing, and 18 induced major splicing anomalies without any trace or minimal amounts (&lt;2.4%) of the minigene full-length (FL) transcript. Twenty-seven transcripts (including the wild-type and r.904A FL transcripts) were identified by fluorescent fragment electrophoresis; of these, 14 were predicted to truncate the RAD51C protein, 3 kept the reading frame, and 8 minor isoforms (1.1–4.7% of the overall expression) could not be characterized. Finally, we performed a tentative interpretation of the variants according to an ACMG/AMP (American College of Medical Genetics and Genomics/Association for Molecular Pathology)-based classification scheme, classifying 16 variants as likely pathogenic. Minigene assays have been proven as valuable tools for the initial characterization of potential spliceogenic variants. Hence, minigene mgR51C_ex2-8 provided useful splicing data for 40 <em>RAD51C</em> variants.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> hereditary breast and ovarian cancer, cancer susceptibility genes, <em>RAD51C</em>, aberrant splicing, functional assay, minigenes, clinical interpretation</p></section></section><section id="sec1-cancers-14-02960"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>A core set of ten genes significantly increases the lifetime risk of developing breast and/or ovarian cancer (BC/OC), as well as other types of cancer [<a href="#B1-cancers-14-02960" class="usa-link" aria-describedby="B1-cancers-14-02960">1</a>]. <em>RAD51C</em> (MIM#602774) loss-of-function variants are significantly associated with BC risk (OR = 1.93), while this association is even greater with estrogen-receptor-negative BC, triple-negative BC, and ovarian cancer (OR = 3.99, 5.71, and 5.59, respectively) [<a href="#B2-cancers-14-02960" class="usa-link" aria-describedby="B2-cancers-14-02960">2</a>,<a href="#B3-cancers-14-02960" class="usa-link" aria-describedby="B3-cancers-14-02960">3</a>,<a href="#B4-cancers-14-02960" class="usa-link" aria-describedby="B4-cancers-14-02960">4</a>]. The main isoform of <em>RAD51C</em> comprises nine exons and encodes a protein essential for DNA repair by homologous recombination. Biallelic <em>RAD51C</em> deleterious variants are also implicated in Fanconi anemia (FANCO) [<a href="#B5-cancers-14-02960" class="usa-link" aria-describedby="B5-cancers-14-02960">5</a>,<a href="#B6-cancers-14-02960" class="usa-link" aria-describedby="B6-cancers-14-02960">6</a>].</p>
<p>Next-generation sequencing (NGS) technology has allowed great progress in breast/ovarian cancer research and diagnostics but has also increased the number of variants of uncertain clinical significance (VUS), whose role in the disease needs to be clarified. This sort of variant hampers the genetic counseling of patients and decision making in the clinical setting [<a href="#B7-cancers-14-02960" class="usa-link" aria-describedby="B7-cancers-14-02960">7</a>]. According to the ClinVar database, around 51% of reported <em>RAD51C</em> variants are VUS (<a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RAD51C%5Bgene%5D" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/clinvar/?term=RAD51C%5Bgene%5D</a>, (accessed on 21 February 2022)).</p>
<p>The reclassification of VUS is essential to ensure appropriate patient care, and functional assays provide critical information for their interpretation [<a href="#B8-cancers-14-02960" class="usa-link" aria-describedby="B8-cancers-14-02960">8</a>,<a href="#B9-cancers-14-02960" class="usa-link" aria-describedby="B9-cancers-14-02960">9</a>,<a href="#B10-cancers-14-02960" class="usa-link" aria-describedby="B10-cancers-14-02960">10</a>,<a href="#B11-cancers-14-02960" class="usa-link" aria-describedby="B11-cancers-14-02960">11</a>]. RNA splicing is one of the gene expression steps that may be impaired by genetic variants [<a href="#B12-cancers-14-02960" class="usa-link" aria-describedby="B12-cancers-14-02960">12</a>,<a href="#B13-cancers-14-02960" class="usa-link" aria-describedby="B13-cancers-14-02960">13</a>]. This process is controlled by a wide array of motifs, such as the consensus 3′ and 5′ splice sites (3′SS and 5′SS, respectively), the polypyrimidine tract, the branchpoint, and other splicing regulatory elements [<a href="#B14-cancers-14-02960" class="usa-link" aria-describedby="B14-cancers-14-02960">14</a>], which represent targets for potential spliceogenic variants. Alterations that result in RNA mis-splicing produce anomalous transcripts and proteins that can trigger a genetic disorder [<a href="#B15-cancers-14-02960" class="usa-link" aria-describedby="B15-cancers-14-02960">15</a>,<a href="#B16-cancers-14-02960" class="usa-link" aria-describedby="B16-cancers-14-02960">16</a>]. Indeed, a high proportion of VUS of the <em>BRCA1</em>, <em>BRCA2</em>, <em>MLH1,</em> and <em>MSH2</em> genes induce splicing disruptions [<a href="#B12-cancers-14-02960" class="usa-link" aria-describedby="B12-cancers-14-02960">12</a>,<a href="#B17-cancers-14-02960" class="usa-link" aria-describedby="B17-cancers-14-02960">17</a>,<a href="#B18-cancers-14-02960" class="usa-link" aria-describedby="B18-cancers-14-02960">18</a>].</p>
<p>In a previous study, we studied 20 <em>RAD51C</em> variants from the large-scale sequencing project BRIDGES (<a href="http://bridges-research.eu/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://bridges-research.eu/</a>, accessed on 21 February 2022) in a splicing-reporter minigene that contains exons 2 to 8 [<a href="#B19-cancers-14-02960" class="usa-link" aria-describedby="B19-cancers-14-02960">19</a>]. In this study, we bioinformatically analyzed 141 variants reported in the ClinVar database and selected another 20 variants for testing by minigene assays. Finally, we suggested a tentative clinical classification of the BRIDGES variants as per ACMG/AMP (American College of Medical Genetics and Genomics and the Association for Molecular Pathology)-based guidelines.</p></section><section id="sec2-cancers-14-02960"><h2 class="pmc_sec_title">2. Materials and Methods</h2>
<section id="sec2dot1-cancers-14-02960"><h3 class="pmc_sec_title">2.1. Ethics Approval</h3>
<p>Ethical approval for this study was obtained from the Ethics Committee of the Spanish National Research Council (CSIC, 28/05/2018).</p></section><section id="sec2dot2-cancers-14-02960"><h3 class="pmc_sec_title">2.2. Annotation of DNA and RNA Variants and Transcripts</h3>
<p>DNA variants, selected from the ClinVar database (<a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RAD51C%5Bgene%5D" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/clinvar/?term=RAD51C%5Bgene%5D</a> (accessed on 21 February 2022)), and alterations at the RNA level were annotated according to the Human Genome Variation Society (HGVS) guidelines (<a href="http://varnomen.hgvs.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://varnomen.hgvs.org/</a>, accessed on 21 February 2022) on the basis of the <em>RAD51C</em> GenBank sequence <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_058216.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_058216.3</a>. For clarity, transcripts were also described using a simplified annotation that combines the following symbols [<a href="#B20-cancers-14-02960" class="usa-link" aria-describedby="B20-cancers-14-02960">20</a>]: ∆ (skipping of exonic sequences); ▼ (inclusion of intronic sequences); E (exon); p (acceptor shift); and q (donor shift). In addition, the last two symbols (p and q) are always followed by the number of nucleotides inserted or deleted from the 3′SS or 5′SS, respectively. For example, Δ(E2p3) refers to the use of an alternative acceptor site 3 nt downstream of exon 2.</p></section><section id="sec2dot3-cancers-14-02960"><h3 class="pmc_sec_title">2.3. Variant Collection and Filtering</h3>
<p>In the ClinVar database, 1316 <em>RAD51C</em> variants have been reported (<a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RAD51C%5Bgene%5D" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/clinvar/?term=RAD51C%5Bgene%5D</a> (accessed 21 February 2022)). A total of 141 were pre-selected, as they were located at the intronic positions ±10 and the first two and last three nucleotides of <em>RAD51C</em> exons 2 to 8 (<a href="#app1-cancers-14-02960" class="usa-link">Supplementary Table S1</a>).</p>
<p>Bioinformatics analysis was performed using the Max Ent Scan (MES) algorithm of the R package SpliceSites version 1.0.0 (<a href="https://www.bioconductor.org/packages//2.13/bioc/html/spliceSites.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.bioconductor.org/packages//2.13/bioc/html/spliceSites.html</a>, accessed on 21 February 2022) and SpliceAI version 1.3.1. (<a href="https://spliceailookup.broadinstitute.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://spliceailookup.broadinstitute.org/</a>, accessed on 21 February 2022) [<a href="#B21-cancers-14-02960" class="usa-link" aria-describedby="B21-cancers-14-02960">21</a>,<a href="#B22-cancers-14-02960" class="usa-link" aria-describedby="B22-cancers-14-02960">22</a>] (<a href="#app1-cancers-14-02960" class="usa-link">Supplementary Table S1</a>). Possible harmful variants were selected according to the following criteria: (i) reduction in MES score by at least 40% (67 variants met this condition); (ii) only one variant per splice-site position unless other events, such as the creation of de novo splice sites or the activation of cryptic ones, were predicted; (iii) prevalence in the ClinVar database, so only variants with at least two records were chosen; and (iv) variants without published reports of splicing assays. Taken together, we finally selected 20 potential spliceogenic variants (totaling 65 ClinVar records) distributed throughout the seven exons of the minigene mgR51C_ex2-8 (<a href="#app1-cancers-14-02960" class="usa-link">Supplementary Table S1</a>). SpliceAI (<a href="https://spliceailookup.broadinstitute.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://spliceailookup.broadinstitute.org/</a>, accessed on 21 February 2022) was also used to predict possible splicing outcomes [<a href="#B22-cancers-14-02960" class="usa-link" aria-describedby="B22-cancers-14-02960">22</a>].</p></section><section id="sec2dot4-cancers-14-02960"><h3 class="pmc_sec_title">2.4. Minigene Construction and Mutagenesis</h3>
<p>We used a minigene with <em>RAD51C</em> exons 2 to 8 (mgR51C_ex2-8) in the splicing vector pSAD [<a href="#B23-cancers-14-02960" class="usa-link" aria-describedby="B23-cancers-14-02960">23</a>,<a href="#B24-cancers-14-02960" class="usa-link" aria-describedby="B24-cancers-14-02960">24</a>], which was constructed as previously described [<a href="#B19-cancers-14-02960" class="usa-link" aria-describedby="B19-cancers-14-02960">19</a>].</p>
<p>The 20 selected variants were incorporated into the wild-type (wt) minigene mgR51C_ex2-8 with the QuikChange Lightning Kit (Agilent, Santa Clara, CA, USA), following the manufacturer’s instructions and using the primers indicated in <a href="#app1-cancers-14-02960" class="usa-link">Supplementary Table S2</a>. All constructs were confirmed by sequencing (Macrogen, Madrid, Spain).</p></section><section id="sec2dot5-cancers-14-02960"><h3 class="pmc_sec_title">2.5. Minigene Splicing Assays</h3>
<p>MCF-7 and MDA-MB-231 cell culture, transfection, and inhibition of the nonsense-mediated decay were performed as previously described [<a href="#B19-cancers-14-02960" class="usa-link" aria-describedby="B19-cancers-14-02960">19</a>,<a href="#B25-cancers-14-02960" class="usa-link" aria-describedby="B25-cancers-14-02960">25</a>].</p>
<p>RNA was purified using the Genematrix Universal RNA Purification Kit (EURx, Gdansk, Poland), with on-column DNAse I digestion. Reverse transcription of 400 ng of RNA was performed using the RevertAid First-Strand cDNA Synthesis Kit (Life Technologies, Carlsbad, CA, USA), following the manufacturer’s instructions and employing the vector-specific primer RTPSPL3-RV (5′-TGAGGAGTGAATTGGTCGAA-3′). The resulting cDNA was amplified using Platinum-Taq DNA polymerase (Life Technologies, Carlsbad, CA, USA) and primers SD6-PSPL3_RT-FW (5′-TCACCTGGACAACCTCAAAG-3′) and RTpSAD-RV (CSIC Patent P201231427) (amplicon size: 1062 nt). Samples were subjected to an initial denaturation step at 94 °C for 2 min; followed by 35 cycles of 94 °C/30 s, 60 °C/30 s, and 72 °C/(1 min/kb); and a final extension step at 72 °C for 5 min. RT-PCR products were sequenced by Macrogen (Madrid, Spain), which allowed the characterization of the main variant-induced transcripts. Minor transcripts were annotated according to fluorescent fragment electrophoresis size data (see below).</p>
<p>To quantify the relative amounts of each PCR product, semi-quantitative fluorescent RT-PCRs were carried out in triplicate using a FAM-labeled primer (RTpSAD-RV for minigene cDNA and RTR51C_ex9-RV for cell cDNA) and 26 PCR cycles [<a href="#B26-cancers-14-02960" class="usa-link" aria-describedby="B26-cancers-14-02960">26</a>]. Fluorescent products were run with the LIZ-1200 size standard at the Macrogen facility (Seoul, Korea) and analyzed using Peak Scanner software V1.0 (Life Technologies). Only peak heights ≥200 RFU (relative fluorescence units) were considered, and mean peak areas of each transcript and standard deviations were calculated. For clarity, the full protocol is schematized in <a href="#app1-cancers-14-02960" class="usa-link">Supplementary Figure S1</a>.</p></section><section id="sec2dot6-cancers-14-02960"><h3 class="pmc_sec_title">2.6. ACMG–AMP Clinical Classification of RAD51C Genetic Variants</h3>
<p>We classified 20 <em>RAD51C</em> genetic variants according to ACMG/AMP-based guidelines [<a href="#B27-cancers-14-02960" class="usa-link" aria-describedby="B27-cancers-14-02960">27</a>]. We followed a recently proposed ACMG/AMP point system, a Bayesian framework that outperforms the original classification guidelines and allows for increased flexibility and accuracy in combining different ACMG/AMP criteria and strengths of evidence [<a href="#B28-cancers-14-02960" class="usa-link" aria-describedby="B28-cancers-14-02960">28</a>,<a href="#B29-cancers-14-02960" class="usa-link" aria-describedby="B29-cancers-14-02960">29</a>]. In this framework, point-based variant classification categories are defined as follows: pathogenic (P) ≥ +10; likely pathogenic (LP) +6 to +9; variant of uncertain significance (VUS) 0 to +5; likely benign (LB) −1 to −6; and benign (B) ≤ −7.</p>
<p>We introduced mgR51C readouts into the classification system as PVS1_O or BP7_O codes of variable evidence strength depending on the splicing outcome (P, supporting (±1 point); M, moderate (±2); strong (±4); very strong (±8)). The use of PVS1_O/BP7_O codes for splicing assays, aimed at highlighting the differences with protein-based functional assays (PS3/BS3 evidence code), was recently introduced by the ClinGen Hereditary Breast, Ovarian, and Pancreatic Cancer Variant Curation Expert Panel (<a href="https://www.clinicalgenome.org/docs/clingen-hereditary-breast-ovarian-and-pancreatic-cancer-expert-panel-specifications-to-the-acmg-amp-variant-interpretation/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.clinicalgenome.org/docs/clingen-hereditary-breast-ovarian-and-pancreatic-cancer-expert-panel-specifications-to-the-acmg-amp-variant-interpretation/</a>, accessed on 2 May 2022) in its <em>ATM</em> rules specifications (HBOPC_ATMv1 specifications).</p>
<p>To deal with complex readouts producing ≥2 transcripts (e.g., a <em>RAD51C</em> variant producing two aberrant transcripts, or a leaky variant producing aberrant and full-length transcripts), we developed several ad hoc rules that take into consideration the coding potential of each individual transcript and its relative contribution to the overall expression to reach the appropriate PVS1_O or BP/_O evidence strength. In brief, for each complex readout, we applied the following algorithm: (i) deconvolute mgR51C readouts into individual transcripts; (ii) apply ACMG/AMP evidence classifications to each individual transcript; (iii) produce an overall PVS1_O (or BP7_O) code strength based on the relative contribution of individual transcripts/evidence to the overall expression. Thus, if pathogenic supporting transcripts contribute ≥90% to the overall expression, the PVS1_O_ code is applied (if different transcripts support different pathogenic evidence strengths, the lowest strength contributing &gt;10% to the overall expression is selected for overall evidence strength). Similarly, the BP7_O_ code is applied if benign supporting transcripts contribute ≥90% to the overall expression (if different transcripts support different pathogenic evidence strengths, the lowest strength contributing &gt;10% to the overall expression is selected for overall evidence strength). If neither pathogenic nor benign supporting transcripts contribute ≥90% to the overall expression, the splicing assay is considered to provide no evidence in favor of, or against, pathogenicity. Recently, we used a similar approach to deal with complex <em>PALB2/ATM</em> minigene readouts [<a href="#B20-cancers-14-02960" class="usa-link" aria-describedby="B20-cancers-14-02960">20</a>,<a href="#B30-cancers-14-02960" class="usa-link" aria-describedby="B30-cancers-14-02960">30</a>].</p>
<p>As already justified in previous studies by our group [<a href="#B19-cancers-14-02960" class="usa-link" aria-describedby="B19-cancers-14-02960">19</a>,<a href="#B20-cancers-14-02960" class="usa-link" aria-describedby="B20-cancers-14-02960">20</a>,<a href="#B25-cancers-14-02960" class="usa-link" aria-describedby="B25-cancers-14-02960">25</a>], once experimental splicing data were available, splicing predictive codes PVS1 and PP3 did not contribute to our final classification. Similarly, in HBOPC_ATMv1 specifications, functional splicing codes replace rather than combine with predictive splicing codes.</p>
<p>The rarity code PM2 was considered as per HBOPC_ATMv1 specifications (<a href="https://clinicalgenome.org/affiliation/50039/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinicalgenome.org/affiliation/50039/</a>, accessed on 2 May 2022) [<a href="#B30-cancers-14-02960" class="usa-link" aria-describedby="B30-cancers-14-02960">30</a>]: (i) allele frequency ≤ 0.01%; (ii) decreasing PM2 evidence strength to ‘supporting’. For allele counting, we interrogated gnomADv2.1 (global). For <em>RAD51C</em> variants absent from gnomADv2.1 (no counts), the actual number of interrogated alleles (allele number) was determined using proxy data on the closest available SNP (in all cases, ≤5 nt apart from the variant of interest).</p></section></section><section id="sec3-cancers-14-02960"><h2 class="pmc_sec_title">3. Results</h2>
<section id="sec3dot1-cancers-14-02960"><h3 class="pmc_sec_title">3.1. In Silico Analysis</h3>
<p>The ClinVar database contains 1316 variants reported for the <em>RAD51C</em> gene, and 141 of them are located at exon/intron boundaries. These variants were bioinformatically analyzed with MES according to the standards indicated in the Materials and Methods section (<a href="#app1-cancers-14-02960" class="usa-link">Supplementary Table S1</a>). Twenty variants from exons 2 to 8 were selected for functional assays (<a href="#cancers-14-02960-t001" class="usa-link">Table 1</a>, <a href="#app1-cancers-14-02960" class="usa-link">Supplementary Table S1</a>, <a href="#cancers-14-02960-f001" class="usa-link">Figure 1</a>a). Fourteen variants affected intronic ±1,2 positions (c.146-4_146-2del, c.404+2T&gt;C, c.405-1G&gt;C, c.571+1del, c.572-1G&gt;C, c.705+1G&gt;A, c.706-1G&gt;T, c.837+1G&gt;T, c.838-2A&gt;G, c.904+1G&gt;T, c.905-3_906del, c.905-2del, c.965+1G&gt;A, and c.966-1G&gt;C); another four altered ±3 nucleotides (c.146-3C&gt;G, c.404+3A&gt;G, c.572-3C&gt;G, and c.705+3A&gt;G); one substituted the last exon nucleotide (c.904G&gt;A); and another affected the +4 intronic position (c.837+4_837+7del).</p>
<section class="tw xbox font-sm" id="cancers-14-02960-t001"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Bioinformatics analysis and splicing outcomes of <em>RAD51C</em> canonical splice variants.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Variant (HGVS) <sup>1</sup>
</th>
<th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Bioinformatics<br>Summary <sup>2</sup>
</th>
<th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Transcripts <sup>3</sup>
</th>
</tr>
<tr>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Canonical</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PTC</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In-Frame</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uncharacterized</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Wild-type</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">98.6% ± 0.2%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1106 nt (1.4% ± 0.2%)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.146-4_146-2del</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]3′SS (9.5→ −0.8)<br>[+]3′SS (5.9) 3 nt downstream</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E2): 73.8% ± 0.8%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E2p3): 25.1% ± 0.4%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">657nt (1.1% ± 0.9%)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.146-3C&gt;G </td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]3′SS (9.5→ 1.9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E2): 94.8% ± 0.9%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E2p3): 5.2% ± 0.9%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.404+2T&gt;C</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]5′SS (4.8→ −3.0)<br>Cr. 5′SS (5.4) 27nt downstream</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">▼(E2q27)-a: 77.2% ± 1.3%<br>Δ(E2): 16.7% ± 0.3%<br>(E2q175): 4.7% ± 0.1%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">657 nt (1.4% ± 1.2%)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.404+3A&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]5′SS (4.8→ 0.6)<br>Cr. 5′SS (5.4) 27 nt downstream</td>
<td align="center" valign="middle" rowspan="1" colspan="1">26.3% ± 0.4%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">▼(E2q27)-b: 66.4% ± 1.6%<br>Δ(E2q175): 5.4% ± 0.3%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">657 nt (1.9% ± 1.6%)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.405-1G&gt;C</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]3′SS (7.7→ −0.4)<br>[+]3′SS (4.2) 7 nt downstream</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E3p7): 48.9 ± 1.6%<br>Δ(E3): 48.2% ± 1.2%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">813 nt (2.9% ± 0.3%)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.571+1del</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]5′SS (10.5→ −14.1)<br>[+]5′SS (11.1) 1 nt upstream</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E3q1): 98.4% ± 1.4%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">800 nt (1.6% ± 1.4%)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.572-3C&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]3′SS (7.4→ −1.4)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E4): 94.7% ± 0.3%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1063 nt (3.0% ± 0.2%)<br>1008 nt (2.3% ± 0.1%)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.572-1G&gt;C</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]3′SS (7.4→ −0.6)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E4): 93.8% ± 0.0%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1008 nt (3.2% ± 0.0%)<br>1063 nt (1.5% ± 0.0%)<br>976 nt (1.5% ± 0.0%)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.705+1G&gt;A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]5′SS (9.1→ 0.9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E4): 100%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.705+3A&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[↓]5′SS (9.1→ 4.6)<br>[+]5′SS (6.1) 2 nt downstream</td>
<td align="center" valign="middle" rowspan="1" colspan="1">21.3% ± 1.3%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E4): 78.7% ± 1.3%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.706-1G&gt;T</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]3′SS (11.1→ 2.5)<br>[+]3′SS (4.3) 10 nt downstream</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E5p10): 100%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.837+1G&gt;T</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]5′SS (8.6→ 0.1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E5): 95.3% ± 0.4%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">976 nt (4.7% ± 0.4)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.837+4_837+7del</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]5′SS (8.6→ −8.9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E5): 100%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.838-2A&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]3′SS (10.2→ 2.2)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E6): 98.4% ± 1.4%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">590 nt (1.6% ± 0.4)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.904G&gt;A<br>(p.Gly302Arg)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]5′SS (5.6→ 1)<br>Cr. 5′SS (6.2) 4 nt downstream</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2.4% ± 0.1%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">▼(E6q4)-a: 97.6% ± 0.1%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.904+1G&gt;T</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]5′SS (5.6→ −3.0)<br>Cr. 5′SS (6.2) 4 nt downstream</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">▼(E6q4)-b: 100%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.905-3_906del</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]3′SS (8.2→ −8.6)<br>[+]3′SS (4.5) 7 nt downstream</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E7): 100%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.905-2del</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]3′SS (8.2→ 2.1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E7): 100%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.965+1G&gt;A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">[−]5′SS (8.7→ 0.5)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Δ(E7): 100%</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.966-1G&gt;C</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[−]3′SS (7.3→ −0.8)<br>[↑] Cr. 3′SS (6.8) 3 nt upstream</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Δ(E8): 20.6% ± 0.1%</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">▼(E8p3): 79.4% ± 0.1%</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/cancers-14-02960-t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn2"><p><sup>1</sup> Variants without any trace (or ≤5%) of the full-length transcript are underlined. <sup>2</sup> [−] Site disruption; [+] new site; [↑] the strength of the SS is increased; Cr. cryptic splice sites of interest; <sup>3</sup> PTC, premature termination codon. The transcripts are named as follows: ∆ (skipping of exonic sequences); ▼ (inclusion of intronic sequences); E (exon); and, when necessary, p (acceptor shift) and q (donor shift) + nt inserted or deleted.</p></div></div></section><figure class="fig xbox font-sm" id="cancers-14-02960-f001"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9221245_cancers-14-02960-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d1/9221245/19b26d258c70/cancers-14-02960-g001.jpg" loading="lazy" height="1080" width="731" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/cancers-14-02960-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Minigene splicing assays of selected ClinVar variants. (<strong>a</strong>) Map of variants in the minigene mgR51C_ex2-8. (<strong>b</strong>) Fluorescent fragment analysis of the ClinVar variants. FAM-labelled products (blue peaks) were run with LIZ1200 (orange peaks) as size standard (FL, minigene full-length transcript). (<strong>c</strong>) High-resolution image of fluorescent fragment electrophoresis that discriminates minimal size differences between transcripts.</p></figcaption></figure><p>Ten of these selected variants were predicted to impair the acceptor site and another ten were expected to impact the donor site. Seven variants (c.146-4_146-2del, c.405-1G&gt;C, c.571+1del, c.705+3A&gt;G, c.706-1G&gt;T, c.905-3_906del, and c.966-1G&gt;C) were predicted to impair the SS and simultaneously create new SSs or strengthen nearby cryptic ones, according to MES. In addition, according to spliceAI, four variants were predicted to promote the use of cryptic splice sites (c.404+2T&gt;C, c.404+3A&gt;G, c.904G&gt;A, and c.904+1G&gt;T).</p></section><section id="sec3dot2-cancers-14-02960"><h3 class="pmc_sec_title">3.2. Functional STUDY</h3>
<p>The RNA analysis of the wt minigene revealed the full-length (mgFL) transcript (V1-<em>RAD51C</em> exons 2 to 8-V2) and traces (1.4%) of an uncharacterized transcript of 1106 nt (<a href="#cancers-14-02960-t001" class="usa-link">Table 1</a>, <a href="#cancers-14-02960-f001" class="usa-link">Figure 1</a>b), as previously reported [<a href="#B19-cancers-14-02960" class="usa-link" aria-describedby="B19-cancers-14-02960">19</a>].</p>
<p>All variants altered splicing: 18 produced no traces of the mgFL transcript or almost undetectable levels (&lt;2.4%, c.904G&gt;A), and it was detected in low proportions (26.3% and 21.3%) in the 2 remaining alterations (c.404+3A&gt;G and c.705+3A&gt;G, respectively) (<a href="#cancers-14-02960-t001" class="usa-link">Table 1</a>). Finally, to check the minigene reproducibility in other cell lines, 3 out of the 20 selected variants (c.405-1G&gt;C, c.706-1G&gt;T, and c.904G&gt;A), as well as the wt minigene, were also tested in the triple-negative breast cancer MDA-MB-231 cells. Fluorescent fragment electrophoresis revealed that MDA-MB-231 cells mimicked the splicing profiles found in MCF-7 cells (<a href="#cancers-14-02960-f002" class="usa-link">Figure 2</a>).</p>
<figure class="fig xbox font-sm" id="cancers-14-02960-f002"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9221245_cancers-14-02960-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d1/9221245/c1ac126385a6/cancers-14-02960-g002.jpg" loading="lazy" height="330" width="794" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/cancers-14-02960-f002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Reproducibility of splicing assays in MDA-MB-231 (<strong>left</strong>) and MCF-7 (<strong>right</strong>) cells. The wild-type and mutant minigenes of c.405-1G&gt;C, c.706-1G&gt;T, and c.904G&gt;A were tested in MCF-7 and MDA-MB-231 cells. RT-PCR products were run on agarose gels.</p></figcaption></figure></section><section id="sec3dot3-cancers-14-02960"><h3 class="pmc_sec_title">3.3. Transcript Analysis and ACMG/AMP-Based Interpretation</h3>
<p>Semi-quantitative fluorescent RT-PCR revealed 27 different aberrant splicing events, including 2 minigene FL transcripts (wt and c.904G&gt;A) (<a href="#cancers-14-02960-f003" class="usa-link">Figure 3</a>, <a href="#app1-cancers-14-02960" class="usa-link">Supplementary Table S3</a>). Nineteen of them could be characterized, and the remaining eight uncharacterized transcripts appeared in low proportions (≤4.7%) and represented, at most, 6.2% of the overall minigene expression (<a href="#cancers-14-02960-t001" class="usa-link">Table 1</a>). A high-resolution image of the fluorescent fragment electrophoresis is illustrated in <a href="#cancers-14-02960-f001" class="usa-link">Figure 1</a>c, where transcripts with small size differences (i.e., 1, 3 nt) can be distinguished. Alternative site usage was the most frequent splicing event; specifically, four aberrant transcripts used cryptic 3′SS (Δ(E2p3), Δ(E3p7), Δ(E5p10), and ▼(E8p3)), and six used alternative 5′SS (▼(E2q27)-a, ▼(E2q27)-b, Δ(E2q175), Δ(E3q1), ▼(E6q4)-a, and ▼(E6q4)-b). The annotations ▼(E2q27)-a and -b reflect the same splicing event (donor shift of exon 2, r.404+27) with different sequences (r.404+2C and r.404+3G, respectively). Similarly, ▼(E6q4)-a and -b indicate the donor shift of exon 6 (r.904+4) with different sequences (r.904A and r.904+1U, respectively). The remaining seven events represented exon skipping (Δ(E2), Δ(E3), Δ(E4), Δ(E5), Δ(E6), Δ(E7), and Δ(E8)).</p>
<figure class="fig xbox font-sm" id="cancers-14-02960-f003"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9221245_cancers-14-02960-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19d1/9221245/6f49e0f71684/cancers-14-02960-g003.jpg" loading="lazy" height="1972" width="686" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/cancers-14-02960-f003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Splicing isoforms generated by <em>RAD51C</em> variants. Diagrams of the splicing reactions. Exons and the splicing reactions are indicated by boxes and elbow arrows, respectively. Anomalous events and exons are indicated in red.</p></figcaption></figure><p>Of the 19 characterized transcripts, 14 introduced premature termination codons (PTC; PTC transcripts), and of these, 10 were predicted to be degraded by the nonsense-mediated decay pathway (NMD; PTC-NMD transcripts), which is considered convincing evidence of deleteriousness (<a href="#app1-cancers-14-02960" class="usa-link">Supplementary Table S3</a>). Following the ACMG/AMP’s proposed PVS1 decision-tree rationale [<a href="#B31-cancers-14-02960" class="usa-link" aria-describedby="B31-cancers-14-02960">31</a>], all PTC-NMD transcripts (<a href="#cancers-14-02960-t001" class="usa-link">Table 1</a>) were classified as very strong evidence of pathogenicity (<a href="#cancers-14-02960-t002" class="usa-link">Table 2</a>). The four PTC non-NMD transcripts, ▼(E6q4)-a (p.Gly302SerFs*47), ▼(E6q4)-b (p.Gly302ValFs*47), Δ(E7) (p.Glu303TrpFs*41), and Δ(E8) (p.Arg322SerFs*22), target RAD51C regions critical for protein function. According to the PVS1 decision-tree rationale, these four PTC transcripts should be considered as strong evidence of pathogenicity. However, these alterations remove β strands 6 to 9 (7 to 9 in the case of Δ(E8)) and the nuclear localization signal [<a href="#B32-cancers-14-02960" class="usa-link" aria-describedby="B32-cancers-14-02960">32</a>,<a href="#B33-cancers-14-02960" class="usa-link" aria-describedby="B33-cancers-14-02960">33</a>]. The integrity of the β sheet is important for maintaining the overall fold of the RAD51C protein and the interaction with RAD51B, so alterations to any β strand of RAD51C should be considered deleterious [<a href="#B33-cancers-14-02960" class="usa-link" aria-describedby="B33-cancers-14-02960">33</a>]. Further, structural features (the order of the β strands in space is not the same as their order in sequence) predict that proteins lacking any single β strand would fail to form the β sheet, resulting in the collapse of the protein core and the misfolding of the protein [<a href="#B33-cancers-14-02960" class="usa-link" aria-describedby="B33-cancers-14-02960">33</a>]. Moreover, the missense variant p.Arg312Trp (β strand 6) has been shown to impair RAD51C function [<a href="#B34-cancers-14-02960" class="usa-link" aria-describedby="B34-cancers-14-02960">34</a>]. Considering these data altogether, we decided to upgrade the pathogenic evidence strength from strong to very strong (<a href="#cancers-14-02960-t001" class="usa-link">Table 1</a> and <a href="#cancers-14-02960-t002" class="usa-link">Table 2</a>). In keeping with this, various PTC variants are classified as pathogenic/likely pathogenic by multiple submitters (no conflicts) in ClinVar.</p>
<section class="tw xbox font-sm" id="cancers-14-02960-t002"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Proposed clinical classification of <em>RAD51C</em> variants according to ACMG/AMP-based criteria.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HGVS <sup>1</sup>
</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ClinVar Accession</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PVS1 <sup>2</sup>
</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PP3/BP4 <sup>3</sup>
</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PVS1_O/BP7_O<br>mgR51C_ex2-8 <sup>4</sup>
</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PM2 <sup>5</sup>
</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">pSAD-based<br>ACMG/AMP-like<br>Classification <sup>6</sup>
</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ClinVar Classification <sup>7</sup>
</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.146-4_146-2del</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000482181.5</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_P (+1)<br>[Δ(E2): 74%, P_VS+<br>Δ(E2p3): 26%, P_P]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/250,394) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VUS (+2)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.146-3C&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000484752.4</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(−79.4%) PP3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[Δ(E2): 95% P_VS +<br>Δ(E2p3): 5% P_P]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/250,394) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VUS</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.404+2T&gt;C</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000182835.10</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[▼(E2q27)-a: 77%, P_VS<br>Δ(E2): 17%, P_VS<br>(E2q175): 5%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(1/246,102) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">P/LP</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.404+3A&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000409857.4</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(−92.5%) PP3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_N/A<br>BP7_O-N/A<br>[▼(E2q27): 66%, P_VS +<br>Δ(E2q175): 5%, P_VS +<br>FL, 27% B_S]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/246,102) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VUS (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VUS</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.405-1G&gt;C</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000141823.5</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[Δ(E3p7): 49%, P_VS<br>Δ(E3): 48%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/251,476) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.571+1del</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000482176.8</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[Δ(E3q1): 98%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(1/251,452) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.572-3C&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000633386.5</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(−99.4%) PP3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[Δ(E4): 95%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/251,198) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VUS</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.572-1G&gt;C</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000480497.10</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[Δ(E4): 94%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/251,220) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">P/LP</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.705+1G&gt;A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000230577.9</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[Δ(E4): 100%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/251,038) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.705+3A&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000241775.7</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(−31.0%) PP3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_N/A<br>BP7_O_N/A<br>[Δ(E4): 79%, P_VS +<br>FL: 21%, B_S]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/250,946) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VUS (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VUS</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.706-1G&gt;T</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000452310.4</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[Δ(E5p10): 100%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/282,746) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.837+1G&gt;T</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000241779.3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[Δ(E5): 95%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/251,374) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.837+4_837+7del</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000128212.8</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(−100.0%) PP3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[Δ(E5): 100%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/251,374) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP(1);VUS(2)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.838-2A&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000480508.3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[Δ(E6): 98%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/250,982) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.904G&gt;A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000478781.9</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(−89.3%) PP3</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[▼(E6q4)-a: 98%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/250,832) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP(1);VUS(3)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.904+1G&gt;T</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000480510.7</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[▼(E6q4)-b: 100%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/250,832) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.905-3_906del</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000182846.7</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[Δ(E7): 100%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/282,730) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">P/LP</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.905-2del</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000230587.7</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[Δ(E7): 100%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/282,730) PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">c.965+1G&gt;A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">VCV000182838.5</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">PVS1_O_VS (+8)<br>[Δ(E7): 100%, P_VS]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(0/ 251118)<br>PM2_P (+1)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP (+9)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LP</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.966-1G&gt;C</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VCV000851327.3</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PVS1</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PVS1_O_P (+1)<br>[Δ(E8): 21%, P_VS +<br>▼(E8p3): 79%, P_P]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(0/251,358) PM2_P (+1)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS (+2)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LP</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/cancers-14-02960-t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn3"><p><sup>1</sup> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_058216.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_058216.3</a>. <sup>2</sup> PVS1 (pathogenic very strong). <sup>3</sup> PP3/BP4 (computational evidence supports a deleterious effect/suggests no impact). <sup>4</sup> PVS1_O code strength derived from mgR51C readouts (P, supporting (±1 point); M, moderate (±2); strong (±4); very Strong (±8)). Percentages of transcripts from <a href="#cancers-14-02960-t001" class="usa-link">Table 1</a> were rounded. <sup>5</sup> Rarity evidence PM2 downgraded to supporting strength, as per ClinGen ATM expert panel ACMG-AMP specifications. For rarity evidence, we used the global gnomADv2.1 data. <sup>6</sup> Predictive evidence codes (PVS1/PP3/BP4) are excluded from our pSAD-based ACMG/AMP-like classification approach. Pathogenic (P) ≥ +10; likely pathogenic (LP) +6 to +9; variant of uncertain significance (VUS) 0 to +5; likely benign (LB) −1 to −6; and benign (B) ≤ −7. <sup>7</sup> ClinVar as of 16 February 2022. For conflicting interpretations of pathogenicity, the number of submitters supporting each interpretation is indicated.</p></div></div></section><p>Three aberrant transcripts kept the open reading frame (Δ(E2p3), Δ(E5), and ▼(E8p3)) (<a href="#cancers-14-02960-t001" class="usa-link">Table 1</a> and <a href="#cancers-14-02960-t002" class="usa-link">Table 2</a>). Δ(E2p3) is a physiological alternative isoform [<a href="#B35-cancers-14-02960" class="usa-link" aria-describedby="B35-cancers-14-02960">35</a>] that deletes the conserved amino acid Glu49 (<a href="#app1-cancers-14-02960" class="usa-link">Supplementary Figure S2</a>). Lacking any evidence other than a deleterious PROVEAN score (- 10.29), we determined that this in-frame transcript provides pathogenic evidence with supporting strength (as per PP3). The predicted protein product of Δ(E5) (p.Arg237_Val280del) deletes the Walker-B domain (β strand 4) and β strand 5. In addition, 26 out of the 44 amino acids encoded by this exon are conserved in vertebrates (<a href="#app1-cancers-14-02960" class="usa-link">Supplementary Figure S2</a>) [<a href="#B19-cancers-14-02960" class="usa-link" aria-describedby="B19-cancers-14-02960">19</a>]. Finally, the exon 5 missense variant c.773G&gt;A (p.Arg258His) is classified as likely pathogenic in ClinVar, because it was found as a biallelic mutation in multiple Fanconi anemia patients of a single family [<a href="#B6-cancers-14-02960" class="usa-link" aria-describedby="B6-cancers-14-02960">6</a>]. Altogether, these observations suggest that Δ(E5) is a loss-of-function transcript that should be catalogued as very strong evidence of pathogenicity (P_VS, +8 points, <a href="#cancers-14-02960-t002" class="usa-link">Table 2</a>). Finally, ▼(E8p3) removes the conserved amino acid Arg322 (β strand 7) and inserts Ser and Thr (p.Arg322delinsSerThr) (<a href="#app1-cancers-14-02960" class="usa-link">Supplementary Figure S2</a>). Based on a deleterious PROVEAN score (−11.94), we determined that this in-frame transcript provides pathogenic evidence with supporting strength (as per PP3).</p>
<p>Finally, one mgFL-transcript carried the missense variant c.904G&gt;A/p.Gly302Arg, where Gly302 is conserved in vertebrates but does not affect a known protein functional domain. In addition, the metapredictor REVEL does not support the pathogenicity of this missense variant (0.5) [<a href="#B36-cancers-14-02960" class="usa-link" aria-describedby="B36-cancers-14-02960">36</a>]. Another nucleotide substitution (c.904G&gt;C), resulting in the same missense variant (p.Gly302Arg), is considered a VUS in ClinVar (REVEL = 0.5).</p>
<p>Thus, mgFL-transcript-c.904G&gt;A does not support any evidence of pathogenicity (P_N/A).</p>
<p>We classified all 20 <em>RAD51C</em> variants according to ACMG-AMP-based classification guidelines, integrating mgR51C data as PVS1_O/BP7_O evidence codes (as indicated above) and the rarity code PM2 (as indicated in Materials and Methods, <a href="#cancers-14-02960-t002" class="usa-link">Table 2</a>). The PM3 evidence (in trans with a pathogenic variant in a recessive disorder) did not contribute to the final classification. Unsurprisingly (FANCO is an extremely rare FA complementation group) [<a href="#B37-cancers-14-02960" class="usa-link" aria-describedby="B37-cancers-14-02960">37</a>], none of the tested variants have been identified in Fanconi anemia patients (ClinVar and Global Variome share LOVD databases and literature searches). Similarly, the BS2 evidence (in trans with a pathogenic variant in a healthy individual) did not contribute to the final classification of our tested variants. Finally, we decided that some pathogenic (PS2, PM1, PM6, PP2, PP4) and benign (BP1, BP3, BP5) codes were not applicable to the classification of <em>RAD51C</em> variants.</p>
<p>Thus, 16 variants were classified as likely pathogenic and 4 as VUS (<a href="#cancers-14-02960-t002" class="usa-link">Table 2</a>). Compared with the ClinVar classification, four variants (c.146-3C&gt;G, c.572-3C&gt;G, c.837+4_837+7del, and c.904G&gt;A) were upgraded from VUS to likely pathogenic, while two variants (c.146-4_146-2del and c.966-1G&gt;C) were downgraded from likely pathogenic to VUS (<a href="#cancers-14-02960-t002" class="usa-link">Table 2</a>).</p></section></section><section id="sec4-cancers-14-02960"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>About 40% of all variants reported in the ClinVar database are variants of uncertain significance (<a href="https://www.ncbi.nlm.nih.gov/clinvar?term=%22clinvar_all%22%5BFilter%5D" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/clinvar?term=%22clinvar_all%22[Filter]</a>, accessed on 21 February 2022). Variants of uncertain significance pose a challenge for genetic counseling testing as they are considered a negative result, and so the risk assessment of VUS-carrier patients is exclusively based on family history [<a href="#B8-cancers-14-02960" class="usa-link" aria-describedby="B8-cancers-14-02960">8</a>,<a href="#B38-cancers-14-02960" class="usa-link" aria-describedby="B38-cancers-14-02960">38</a>]. A significant fraction of VUS impair pre-mRNA splicing, which makes transcript analysis a mandatory step for determining their pathogenicity [<a href="#B39-cancers-14-02960" class="usa-link" aria-describedby="B39-cancers-14-02960">39</a>].</p>
<p>Conversely, many splicing variants are classified as likely pathogenic or pathogenic because they target the canonical ±1, 2 splice-site positions. While it is true that most of these variants will impact splicing, the resulting alteration is not necessarily pathogenic. For example, variants affecting the 3′SS of <em>RAD51C</em> exon 8, such as c.966-2A&gt;G (functionally analyzed in our previous <em>RAD51C</em> study [<a href="#B19-cancers-14-02960" class="usa-link" aria-describedby="B19-cancers-14-02960">19</a>]) and c.966-1G&gt;C (studied here), are classified as likely pathogenic by ClinVar because they alter the -2 and -1 positions, respectively. Nevertheless, these variants cause a 3 nt insertion (one amino acid) with an unknown impact on protein function, and so they are classified as VUS (<a href="#cancers-14-02960-t002" class="usa-link">Table 2</a>). This observation underlines the importance of the functional testing of suspicious splicing variants [<a href="#B14-cancers-14-02960" class="usa-link" aria-describedby="B14-cancers-14-02960">14</a>,<a href="#B40-cancers-14-02960" class="usa-link" aria-describedby="B40-cancers-14-02960">40</a>].</p>
<p>Here, we focused on potentially spliceogenic <em>RAD51C</em> variants reported in the ClinVar database. Functional studies were performed using a hybrid minigene (mgR51C_ex2-8) that has proven to be a powerful and reliable tool for testing variant-splicing outcomes in the absence of patient RNA [<a href="#B19-cancers-14-02960" class="usa-link" aria-describedby="B19-cancers-14-02960">19</a>]. The major advantages of minigene-based assays are: (a) no need for patient samples; (b) no interference from the wt allele, as occurs in patient RNA, so all the observed transcripts are generated by the variant; (c) assays can be performed on disease-relevant cell types; and (d) a single construct allows the study of multiple variants. Indeed, this <em>RAD51C</em> minigene has allowed the functional analysis of a total of 40 variants to date (<a href="#cancers-14-02960-t003" class="usa-link">Table 3</a>), but the functional analysis of any candidate variant located at exons 2 to 8 would be possible. Finally, the high sensitivity and resolution of the fluorescent fragment electrophoresis, which facilitated the detection of rare transcripts and resolved small size differences between them, is also worth mentioning.</p>
<section class="tw xbox font-sm" id="cancers-14-02960-t003"><h3 class="obj_head">Table 3.</h3>
<div class="caption p"><p>Summary of the 40 variants tested in minigene mgR51C_ex2-8.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<em>RAD51C</em> Variant</th>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Splicing Motif <sup>1</sup>
</th>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Splicing Outcome <sup>2</sup>
</th>
<th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Clinical Interpretation</th>
</tr></thead>
<tbody>
<tr><td colspan="4" align="left" valign="middle" rowspan="1">Exon 2</td></tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.146-4_146-2del</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[±]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E2): 73.8%; Δ(E2p3): 25.1% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">VUS</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.146-3C&gt;T</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">100% mgFL-transcript</td>
<td align="left" valign="middle" rowspan="1" colspan="1">VUS <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.146-3C&gt;G</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E2): 94.8%; Δ(E2p3): 5.2% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.404G&gt;A</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">▼(E2q27): 69.3%; Δ(E2q175): 19.9%; Δ(E2q22): 4.3%; Δ(E2): 2.4% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.404+2T&gt;C</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">▼(E2q27): 77.2%; Δ(E2): 16.7%; (E2q175): 4.7%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.404+3A&gt;G</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">▼(E2q27): 66.4%; mgFL: 26.3%; Δ(E2q175): 5.4%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">VUS</td>
</tr>
<tr><td colspan="4" align="left" valign="middle" rowspan="1">Exon 3</td></tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.405-6T&gt;A</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[±]3′SS/Pyr</td>
<td align="left" valign="middle" rowspan="1" colspan="1">▼(E3p4):95.2%; Δ(E3): 4.8%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.405-1G&gt;C</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[±]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E3p7): 48.9%; Δ(E3): 48.2%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.571+1del</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[±]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E3q1): 98.4%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.571+4A&gt;G</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[±]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E3): 76.5%; ▼(E3q4): 11.6%; FL: 5.4%; Δ(E3q114): 4.0%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.571+5G&gt;A</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E3): 91.5%; Δ(E3q114): 4.8% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">Pathogenic <sup>3</sup>
</td>
</tr>
<tr><td colspan="4" align="left" valign="middle" rowspan="1">Exon 4</td></tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.572-3C&gt;G</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E4): 94.7%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.572-1G&gt;C</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E4): 93.8%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.572-1G&gt;T</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E4): 93.4% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.705G&gt;T</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E4): 100%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.705+1G&gt;A</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E4): 100%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.705+3A&gt;G</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E4): 78.7%; mgFL: 21.3%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">VUS</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.705+5G&gt;C</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">mgFL: 51.6%; Δ(E4): 48.4% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">VUS <sup>3</sup>
</td>
</tr>
<tr><td colspan="4" align="left" valign="middle" rowspan="1">Exon 5</td></tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.706-2A&gt;C</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[±]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E5p10): 91.4%; Δ(E5): 4.0%; Δ(E5p52): 1.8%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.706-2A&gt;G</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[±]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E5): 65.4%; Δ(E5p10): 33.5%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Pathogenic <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.706-1G&gt;T</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[±]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E5p10): 100% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.837+1G&gt;T</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E5): 95.3% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.837+2T&gt;C</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E5): 89.3%; Δ(E4_5): 2.2% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.837+4_837+7del</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E5): 100%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr><td colspan="4" align="left" valign="middle" rowspan="1">Exon 6</td></tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.838-2A&gt;G</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E6): 98.4% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.904G&gt;A</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">▼(E6q4): 97.6%; FL: 2.4% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.904+1G&gt;T</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">▼(E6q4): 100% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr><td colspan="4" align="left" valign="middle" rowspan="1">Exon 7</td></tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.905-3_906del</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E7): 100%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.905-3C&gt;G</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E7): 98.1%; Δ(E7_8): 1.9% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.905-2del</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E7): 100%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.905-2A&gt;C</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E7): 97.4 %</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Pathogenic <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.905-2_905-1del</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E7): 100%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Pathogenic <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.965+1G&gt;A</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E7): 100%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.965+5G&gt;A</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E7): 100%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Likely Pathogenic <sup>3</sup>
</td>
</tr>
<tr><td colspan="4" align="left" valign="middle" rowspan="1">Exon 8</td></tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.966-3C&gt;A</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E8): 86.8%; ▼(E8p3): 9.7%; FL: 2%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">VUS <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.966-2A&gt;G</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[±]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E8): 86.7%; ▼(E8p3):11.0% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">VUS <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.966-2A&gt;T</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[±]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E8): 89.1%; ▼(E8p3):5.9% </td>
<td align="left" valign="middle" rowspan="1" colspan="1">VUS <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.966-1G&gt;C</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[±]3′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">▼(E8p3): 79.4%; Δ(E8): 20.6%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">VUS</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="1" colspan="1">c.1026+5_1026+7del</td>
<td align="left" valign="middle" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Δ(E8): 79.5%; Δ(E8q18):13.8%; ▼(E8q41): 3.3%</td>
<td align="left" valign="middle" rowspan="1" colspan="1">Pathogenic <sup>3</sup>
</td>
</tr>
<tr>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1026+5G&gt;T</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[−]5′SS</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Δ(E8): 78.0%; Δ(E8q18):18.7%; ▼(E8q44): 1.4%</td>
<td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Likely Pathogenic <sup>3</sup>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/cancers-14-02960-t003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn4"><p><sup>1</sup> [−] Site disruption; [+] new site; [±] simultaneous creation/strengthening of cryptic site and disruption; Pyr, polypyrimidine tract. <sup>2</sup> Only characterized transcripts are shown in this column; transcripts are named as follows: ∆ (skipping of exonic sequences); ▼ (inclusion of intronic sequences); E (exon); and, when necessary, p (acceptor shift) and q (donor shift) + nt inserted or deleted; FL, full-length. <sup>3</sup> ACMG/AMP-based interpretation according to Sanoguera-Miralles et al., 2020 [<a href="#B19-cancers-14-02960" class="usa-link" aria-describedby="B19-cancers-14-02960">19</a>].</p></div></div></section><p>All variants tested impair splicing, underlining the specificity of our selection criteria. MES accurately predicted all the splicing disruptions, indicating that the selection criterion of a ≤40% MES score reduction was appropriate. In general, splicing outcomes predicted by SpliceAI were precise, except for variants c.705+3A&gt;G, c.904+1G&gt;T, and c.966-1G&gt;C (<a href="#app1-cancers-14-02960" class="usa-link">Supplementary Table S1</a>; <a href="#cancers-14-02960-t001" class="usa-link">Table 1</a>). Indeed, it is realistically impossible to forecast all variant-induced transcripts, given that most variants generate ≥2 different transcripts, and so, as indicated above, RNA assays are compulsory to clinically classify them. Fluorescent fragment electrophoresis allowed us to detect 27 different RNA isoforms, 19 of which could be characterized (<a href="#cancers-14-02960-t001" class="usa-link">Table 1</a>, <a href="#cancers-14-02960-f001" class="usa-link">Figure 1</a> and <a href="#cancers-14-02960-f003" class="usa-link">Figure 3</a>, <a href="#app1-cancers-14-02960" class="usa-link">Supplementary Table S3</a>). Seven of them were generated by exon skipping (Δ(E2), Δ(E3), Δ(E4), Δ(E5), Δ(E6), Δ(E7), and Δ(E8)); four by alternative 3′SS usage (Δ(E2p3), Δ(E3p7), Δ(E5p10), and ▼(E8p3)); and six involved the use of cryptic/de novo 5′SS (▼(E2q27)-a,b, Δ(E2q175), Δ(E3q1), and ▼(E6q4)-a,b). Remarkably, 10 variant-induced transcripts (Δ(E2p3), ▼(E2q27), Δ(E2q175), Δ(E2), Δ(E3), Δ(E4), Δ(E5), Δ(E7), Δ(E8), and ▼(E8p3)) had been previously characterized as naturally occurring isoforms of <em>RAD51C</em> [<a href="#B35-cancers-14-02960" class="usa-link" aria-describedby="B35-cancers-14-02960">35</a>], suggesting that alternative events may match, at least in part, variant-splicing profiles.</p>
<p>Only two variants (c.404+3A&gt;G and c.705+3A&gt;G) displayed 26% and 21% of the mgFL transcript, respectively. Unfortunately, the minimal amount of <em>RAD51C</em> expression required to confer tumor-suppressor haplosufficiency is unknown, and so these splicing assays were not considered informative (PVS1_O_N/A). Interestingly, both alter the intronic position +3 (<a href="#cancers-14-02960-t001" class="usa-link">Table 1</a>). Remarkably, +3A is the main nucleotide at this position (59.1%), but +3G is also relatively frequent (34.2%), highlighting the importance of both nucleotides for 5′-SS selection [<a href="#B41-cancers-14-02960" class="usa-link" aria-describedby="B41-cancers-14-02960">41</a>]. Our previous studies of +3 changes to G revealed diverse effects. While some exhibited no trace of the mgFL transcript (or small amounts ≤10%) (<em>BRCA2</em> c.67+3A&gt;G, c.631+3A&gt;G, and c.8487+3A&gt;G; <em>BRCA1</em> c.212+3A&gt;G; and <em>PALB2</em> c.3113+3A&gt;G), others did not even affect the splicing process (or showed weak effects) (<em>BRCA2</em> c.7435+3A&gt;G and <em>PALB2</em> c.2834+3A&gt;G) [<a href="#B12-cancers-14-02960" class="usa-link" aria-describedby="B12-cancers-14-02960">12</a>,<a href="#B42-cancers-14-02960" class="usa-link" aria-describedby="B42-cancers-14-02960">42</a>,<a href="#B43-cancers-14-02960" class="usa-link" aria-describedby="B43-cancers-14-02960">43</a>,<a href="#B44-cancers-14-02960" class="usa-link" aria-describedby="B44-cancers-14-02960">44</a>]. Previous papers have suggested that such transitions are deleterious when the affected 5′SS have non-consensus nucleotides in the adjacent +4 and +5 positions [<a href="#B45-cancers-14-02960" class="usa-link" aria-describedby="B45-cancers-14-02960">45</a>,<a href="#B46-cancers-14-02960" class="usa-link" aria-describedby="B46-cancers-14-02960">46</a>]. However, we found that most +3A&gt;G variants do not follow this simple +4,+5 mismatch rule [<a href="#B20-cancers-14-02960" class="usa-link" aria-describedby="B20-cancers-14-02960">20</a>,<a href="#B43-cancers-14-02960" class="usa-link" aria-describedby="B43-cancers-14-02960">43</a>,<a href="#B44-cancers-14-02960" class="usa-link" aria-describedby="B44-cancers-14-02960">44</a>].</p>
<p>We also focused our attention on substitutions of +2T&gt;C, by means of which a canonical GT 5′ SS is converted into an atypical GC 5′ SS that accounts for less than 1% of human donor sites [<a href="#B47-cancers-14-02960" class="usa-link" aria-describedby="B47-cancers-14-02960">47</a>]. It has been reported that about 15–18% of +2T&gt;C changes retain the activity of the donor site [<a href="#B48-cancers-14-02960" class="usa-link" aria-describedby="B48-cancers-14-02960">48</a>], inducing between 1 and 84% of full-length transcripts. Remarkably, neither of the two genetic alterations that introduce a cytosine at position +2 (c.404+2T&gt;C and c.837+2T&gt;C) use the de novo atypical GC dinucleotide (<a href="#cancers-14-02960-t002" class="usa-link">Table 2</a>), e.g., the <em>PALB2</em> variant c.48+2T&gt;C [<a href="#B19-cancers-14-02960" class="usa-link" aria-describedby="B19-cancers-14-02960">19</a>,<a href="#B20-cancers-14-02960" class="usa-link" aria-describedby="B20-cancers-14-02960">20</a>]. Conversely, we previously showed that <em>PALB2</em> c.108+2T&gt;C generated an active GC-5′SS that produced 85% of full-length transcripts [<a href="#B20-cancers-14-02960" class="usa-link" aria-describedby="B20-cancers-14-02960">20</a>]. This feature may be related to the high sequence conservation of the other splice-site positions (CAG|GCAAGT).</p>
<p>On the other hand, c.966-1G&gt;C mainly induced the use of an alternative 3′SS (▼(E8p3), 79%), which we had also detected in variants c.966-3C&gt;A, c.966-2A&gt;G, and c.966-2A&gt;T, though in lower amounts (6–11%) [<a href="#B19-cancers-14-02960" class="usa-link" aria-describedby="B19-cancers-14-02960">19</a>]. As indicated above, the 3 nt insertion ▼(E8p3) represents four different transcripts and four different protein products (Arg deletion/SerThr insertion, Arg duplication, Arg deletion/SerGly insertion, and Arg deletion/SerTrp insertion), which hinder transcript interpretation to an even greater extent.</p></section><section id="sec5-cancers-14-02960"><h2 class="pmc_sec_title">5. Conclusions</h2>
<p>We tested a total of 40 <em>RAD51C</em> variants in the minigene mgR51C_ex2-8, of which 39 impaired splicing and 36 were associated with severe splicing aberrations (<a href="#cancers-14-02960-t003" class="usa-link">Table 3</a>). Thirty-one variants were classified as likely pathogenic/pathogenic as per ACMG/AMP-based guidelines, while nine were catalogued as VUS. Moreover, according to ClinVar records of 34 reported variants (including those of our previous study) [<a href="#B19-cancers-14-02960" class="usa-link" aria-describedby="B19-cancers-14-02960">19</a>], the mgR51C readouts changed the clinical interpretation of 12 variants: 9 VUS were upgraded to likely pathogenic and 3 LP variants were downgraded to VUS. Both changes are critical for genetic counseling and decision making in the clinical setting, reaffirming the value of minigene assays. Finally, it is critical to define the minimal amount of <em>RAD51C</em> required to maintain gene function. Hence, it is conceivable that the variants with the vast majority of inactivating transcripts, such as c.966-3C&gt;A, c.966-2A&gt;G, and c.966-2A&gt;T (&gt;86% of PTC transcripts), might be reclassified as likely pathogenic or pathogenic.</p></section><section id="app1-cancers-14-02960" class="app"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<p>The following supporting information can be downloaded at: <a href="https://www.mdpi.com/article/10.3390/cancers14122960/s1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.mdpi.com/article/10.3390/cancers14122960/s1</a>, Figure S1: Workflow of the minigene protocol, Figure S2: Alignment and amino acid conservation of the RAD51C protein, Table S1: Bioinformatics analysis of <em>RAD51C</em> variants with Max Ent Score, Table S2: Mutagenesis primers for <em>RAD51C</em> variants, Table S3: Transcript annotation according to HGVS guidelines.</p>
<section class="sm xbox font-sm" id="cancers-14-02960-s001"><div class="media p"><div class="caption">
<a href="/articles/instance/9221245/bin/cancers-14-02960-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (3.3MB, zip) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Conceptualization, E.A.V.-S.; data curation, L.S.-M., formal analysis, E.B.-M., L.S.-M., A.V.-P., A.E.-S., M.d.l.H. and E.A.V.-S.; funding acquisition, M.d.l.H. and E.A.V.-S.; investigation, E.B.-M., L.S.-M., A.V.-P., A.E.-S., I.L.-B., P.P.-S., A.G.-Á., M.d.l.H. and E.A.V.-S.; methodology, A.V.-P., L.S.-M., E.B.-M., I.L.-B., A.G.-Á. and E.A.V.-S.; supervision, E.A.V.-S.; writing—original draft, L.S.-M. and E.A.V.-S.; writing—review and editing, L.S.-M., M.d.l.H. and E.A.V.-S. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Institutional Review Board Statement</h2>
<p>This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Spanish National Research Council (28/05/2018) (Consejo Superior de Investigaciones Científicas, CSIC).</p></section><section id="notes3"><h2 class="pmc_sec_title">Informed Consent Statement</h2>
<p>Not applicable.</p></section><section id="notes4"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>All sequencing and fragment analysis data are available at <a href="http://hdl.handle.net/10261/270934" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://hdl.handle.net/10261/270934</a>; <a href="https://doi.org/10.20350/digitalCSIC/14662" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.20350/digitalCSIC/14662</a>, accessed on 15 June 2022.</p></section><section id="notes5"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflict of interest.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The EAV lab is supported by grants from the Spanish Ministry of Science and Innovation, Plan Nacional de I+D+I 2013–2016, ISCIII (PI17/00227 and PI20/00225), co-funded by FEDER (the European Regional Development Fund, European Union) and the Consejería de Educación, Junta de Castilla y León, ref. CSI242P18 (actuación cofinanciada P.O. FEDER 2014–2020 de Castilla y León) and Programa Estratégico Instituto de Biología y Genética Molecular (IBGM), Escalera de Excelencia, Junta de Castilla y León (Ref. CLU-2019-02). The MdlH lab is supported by a grant from the Spanish Ministry of Science and Innovation, Plan Nacional de I+D+I 2013–2016, ISCIII (PI20/00110), co-funded by FEDER. LS-M is supported by a predoctoral fellowship from the AECC Scientific Foundation, Sede Provincial de Valladolid (2019–2023). EB-M is a postdoctoral researcher funded by the University of Valladolid (POSTDOC-UVA05, 2022–2025). IL-B is supported by a predoctoral fellowship from the Consejería de Educación, Junta de Castilla y León (2018–2022). AE-S is supported through the Operational Program for Youth Employment and the Youth Employment Initiative (YEI), set up by the Community of Madrid in 2020 and co-financed by the European Social Fund.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1"><p><strong>Publisher’s Note:</strong> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-cancers-14-02960">
<span class="label">1.</span><cite>Foulkes W.D. The ten genes for breast (and ovarian) cancer susceptibility. Nat. Rev. Clin. Oncol. 2021;18:259–260. doi: 10.1038/s41571-021-00491-3.</cite> [<a href="https://doi.org/10.1038/s41571-021-00491-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33692540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Clin.%20Oncol.&amp;title=The%20ten%20genes%20for%20breast%20(and%20ovarian)%20cancer%20susceptibility&amp;author=W.D.%20Foulkes&amp;volume=18&amp;publication_year=2021&amp;pages=259-260&amp;pmid=33692540&amp;doi=10.1038/s41571-021-00491-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-cancers-14-02960">
<span class="label">2.</span><cite>Dorling L., Carvalho S., Allen J., González-Neira A., Luccarini C., Wahlström C., Pooley K.A., Parsons M.T., Fortuno C., Wang Q., et al.  Breast Cancer Risk Genes—Association Analysis in More than 113,000 Women. N. Engl. J. Med. 2021;384:428–439. doi: 10.1056/NEJMoa1913948.</cite> [<a href="https://doi.org/10.1056/NEJMoa1913948" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7611105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33471991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Breast%20Cancer%20Risk%20Genes%E2%80%94Association%20Analysis%20in%20More%20than%20113,000%20Women&amp;author=L.%20Dorling&amp;author=S.%20Carvalho&amp;author=J.%20Allen&amp;author=A.%20Gonz%C3%A1lez-Neira&amp;author=C.%20Luccarini&amp;volume=384&amp;publication_year=2021&amp;pages=428-439&amp;pmid=33471991&amp;doi=10.1056/NEJMoa1913948&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-cancers-14-02960">
<span class="label">3.</span><cite>Meindl A., Hellebrand H., Wiek C., Erven V., Wappenschmidt B., Niederacher D., Freund M., Lichtner P., Hartmann L., Schaal H., et al.  Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat. Genet. 2010;42:410–414. doi: 10.1038/ng.569.</cite> [<a href="https://doi.org/10.1038/ng.569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20400964/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Genet.&amp;title=Germline%20mutations%20in%20breast%20and%20ovarian%20cancer%20pedigrees%20establish%20RAD51C%20as%20a%20human%20cancer%20susceptibility%20gene&amp;author=A.%20Meindl&amp;author=H.%20Hellebrand&amp;author=C.%20Wiek&amp;author=V.%20Erven&amp;author=B.%20Wappenschmidt&amp;volume=42&amp;publication_year=2010&amp;pages=410-414&amp;pmid=20400964&amp;doi=10.1038/ng.569&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-cancers-14-02960">
<span class="label">4.</span><cite>Suszynska M., Ratajska M., Kozlowski P. BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: Mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases. J. Ovarian Res. 2020;13:50. doi: 10.1186/s13048-020-00654-3.</cite> [<a href="https://doi.org/10.1186/s13048-020-00654-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7196220/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32359370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Ovarian%20Res.&amp;title=BRIP1,%20RAD51C,%20and%20RAD51D%20mutations%20are%20associated%20with%20high%20susceptibility%20to%20ovarian%20cancer:%20Mutation%20prevalence%20and%20precise%20risk%20estimates%20based%20on%20a%20pooled%20analysis%20of%20~30,000%20cases&amp;author=M.%20Suszynska&amp;author=M.%20Ratajska&amp;author=P.%20Kozlowski&amp;volume=13&amp;publication_year=2020&amp;pages=50&amp;pmid=32359370&amp;doi=10.1186/s13048-020-00654-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5-cancers-14-02960">
<span class="label">5.</span><cite>Somyajit K., Subramanya S., Nagaraju G. RAD51C: A novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer. Carcinogenesis. 2010;31:2031–2038. doi: 10.1093/carcin/bgq210.</cite> [<a href="https://doi.org/10.1093/carcin/bgq210" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2994284/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20952512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=RAD51C:%20A%20novel%20cancer%20susceptibility%20gene%20is%20linked%20to%20Fanconi%20anemia%20and%20breast%20cancer&amp;author=K.%20Somyajit&amp;author=S.%20Subramanya&amp;author=G.%20Nagaraju&amp;volume=31&amp;publication_year=2010&amp;pages=2031-2038&amp;pmid=20952512&amp;doi=10.1093/carcin/bgq210&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-cancers-14-02960">
<span class="label">6.</span><cite>Vaz F., Hanenberg H., Schuster B., Barker K., Wiek C., Erven V., Neveling K., Endt D., Kesterton I., Autore F., et al.  Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat. Genet. 2010;42:406–409. doi: 10.1038/ng.570.</cite> [<a href="https://doi.org/10.1038/ng.570" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20400963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Genet.&amp;title=Mutation%20of%20the%20RAD51C%20gene%20in%20a%20Fanconi%20anemia-like%20disorder&amp;author=F.%20Vaz&amp;author=H.%20Hanenberg&amp;author=B.%20Schuster&amp;author=K.%20Barker&amp;author=C.%20Wiek&amp;volume=42&amp;publication_year=2010&amp;pages=406-409&amp;pmid=20400963&amp;doi=10.1038/ng.570&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-cancers-14-02960">
<span class="label">7.</span><cite>Radice P., de Summa S., Caleca L., Tommasi S. Unclassified variants in BRCA genes: Guidelines for interpretation. Ann. Oncol. 2011;22:i18–i23. doi: 10.1093/annonc/mdq661.</cite> [<a href="https://doi.org/10.1093/annonc/mdq661" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21285146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Oncol.&amp;title=Unclassified%20variants%20in%20BRCA%20genes:%20Guidelines%20for%20interpretation&amp;author=P.%20Radice&amp;author=S.%20de%20Summa&amp;author=L.%20Caleca&amp;author=S.%20Tommasi&amp;volume=22&amp;publication_year=2011&amp;pages=i18-i23&amp;pmid=21285146&amp;doi=10.1093/annonc/mdq661&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-cancers-14-02960">
<span class="label">8.</span><cite>Federici G., Soddu S. Variants of uncertain significance in the era of high-throughput genome sequencing: A lesson from breast and ovary cancers. J. Exp. Clin. Cancer Res. 2020;39:46. doi: 10.1186/s13046-020-01554-6.</cite> [<a href="https://doi.org/10.1186/s13046-020-01554-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7055088/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32127026/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Exp.%20Clin.%20Cancer%20Res.&amp;title=Variants%20of%20uncertain%20significance%20in%20the%20era%20of%20high-throughput%20genome%20sequencing:%20A%20lesson%20from%20breast%20and%20ovary%20cancers&amp;author=G.%20Federici&amp;author=S.%20Soddu&amp;volume=39&amp;publication_year=2020&amp;pages=46&amp;pmid=32127026&amp;doi=10.1186/s13046-020-01554-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-cancers-14-02960">
<span class="label">9.</span><cite>Zelli V., Compagnoni C., Cannita K., Capelli R., Capalbo C., Nolfi M.D.V., Alesse E., Zazzeroni F., Tessitore A. Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer. High-Throughput. 2020;9:1.  doi: 10.3390/ht9010001.</cite> [<a href="https://doi.org/10.3390/ht9010001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7151204/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31936873/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=High-Throughput&amp;title=Applications%20of%20Next%20Generation%20Sequencing%20to%20the%20Analysis%20of%20Familial%20Breast/Ovarian%20Cancer&amp;author=V.%20Zelli&amp;author=C.%20Compagnoni&amp;author=K.%20Cannita&amp;author=R.%20Capelli&amp;author=C.%20Capalbo&amp;volume=9&amp;publication_year=2020&amp;pages=1&amp;pmid=31936873&amp;doi=10.3390/ht9010001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-cancers-14-02960">
<span class="label">10.</span><cite>McAlarnen L., Stearns K., Uyar D. Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers. Appl. Clin. Genet. 2021;14:1–9. doi: 10.2147/TACG.S245021.</cite> [<a href="https://doi.org/10.2147/TACG.S245021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7814235/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33488111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Appl.%20Clin.%20Genet.&amp;title=Challenges%20of%20Genomic%20Testing%20for%20Hereditary%20Breast%20and%20Ovarian%20Cancers&amp;author=L.%20McAlarnen&amp;author=K.%20Stearns&amp;author=D.%20Uyar&amp;volume=14&amp;publication_year=2021&amp;pages=1-9&amp;pmid=33488111&amp;doi=10.2147/TACG.S245021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-cancers-14-02960">
<span class="label">11.</span><cite>Alenezi W.M., Milano L., Fierheller C.T., Serruya C., Revil T., Oros K.K., Behl S., Arcand S.L., Nayar P., Spiegelman D., et al.  The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population. Cancers. 2022;14:2251.  doi: 10.3390/cancers14092251.</cite> [<a href="https://doi.org/10.3390/cancers14092251" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9104874/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35565380/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=The%20Genetic%20and%20Molecular%20Analyses%20of%20RAD51C%20and%20RAD51D%20Identifies%20Rare%20Variants%20Implicated%20in%20Hereditary%20Ovarian%20Cancer%20from%20a%20Genetically%20Unique%20Population&amp;author=W.M.%20Alenezi&amp;author=L.%20Milano&amp;author=C.T.%20Fierheller&amp;author=C.%20Serruya&amp;author=T.%20Revil&amp;volume=14&amp;publication_year=2022&amp;pages=2251&amp;pmid=35565380&amp;doi=10.3390/cancers14092251&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-cancers-14-02960">
<span class="label">12.</span><cite>Sanz D.J., Acedo A., Infante M., Durán M., Pérez-Cabornero L., Esteban-Cardeñosa E., Lastra E., Pagani F., Miner C., Velasco E.A. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients. Clin. Cancer Res. 2010;16:1957–1967. doi: 10.1158/1078-0432.CCR-09-2564.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-09-2564" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20215541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&amp;title=A%20high%20proportion%20of%20DNA%20variants%20of%20BRCA1%20and%20BRCA2%20is%20associated%20with%20aberrant%20splicing%20in%20breast/ovarian%20cancer%20patients&amp;author=D.J.%20Sanz&amp;author=A.%20Acedo&amp;author=M.%20Infante&amp;author=M.%20Dur%C3%A1n&amp;author=L.%20P%C3%A9rez-Cabornero&amp;volume=16&amp;publication_year=2010&amp;pages=1957-1967&amp;pmid=20215541&amp;doi=10.1158/1078-0432.CCR-09-2564&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-cancers-14-02960">
<span class="label">13.</span><cite>Rhine C.L., Cygan K.J., Soemedi R., Maguire S., Murray M.F., Monaghan S.F., Fairbrother W.G. Hereditary cancer genes are highly susceptible to splicing mutations. PLoS Genet. 2018;14:e1007231.  doi: 10.1371/journal.pgen.1007231.</cite> [<a href="https://doi.org/10.1371/journal.pgen.1007231" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5854443/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29505604/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genet.&amp;title=Hereditary%20cancer%20genes%20are%20highly%20susceptible%20to%20splicing%20mutations&amp;author=C.L.%20Rhine&amp;author=K.J.%20Cygan&amp;author=R.%20Soemedi&amp;author=S.%20Maguire&amp;author=M.F.%20Murray&amp;volume=14&amp;publication_year=2018&amp;pages=e1007231&amp;pmid=29505604&amp;doi=10.1371/journal.pgen.1007231&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-cancers-14-02960">
<span class="label">14.</span><cite>Abramowicz A., Gos M. Splicing mutations in human genetic disorders: Examples, detection, and confirmation. J. Appl. Genet. 2018;59:253–268. doi: 10.1007/s13353-019-00493-z.</cite> [<a href="https://doi.org/10.1007/s13353-019-00493-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6060985/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29680930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Appl.%20Genet.&amp;title=Splicing%20mutations%20in%20human%20genetic%20disorders:%20Examples,%20detection,%20and%20confirmation&amp;author=A.%20Abramowicz&amp;author=M.%20Gos&amp;volume=59&amp;publication_year=2018&amp;pages=253-268&amp;pmid=29680930&amp;doi=10.1007/s13353-019-00493-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-cancers-14-02960">
<span class="label">15.</span><cite>Scotti M.M., Swanson M.S. RNA mis-splicing in disease. Nat. Rev. Genet. 2016;17:19–32. doi: 10.1038/nrg.2015.3.</cite> [<a href="https://doi.org/10.1038/nrg.2015.3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5993438/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26593421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Genet.&amp;title=RNA%20mis-splicing%20in%20disease&amp;author=M.M.%20Scotti&amp;author=M.S.%20Swanson&amp;volume=17&amp;publication_year=2016&amp;pages=19-32&amp;pmid=26593421&amp;doi=10.1038/nrg.2015.3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16-cancers-14-02960">
<span class="label">16.</span><cite>Asselta R., Duga S., Velasco E.A., Buratti E. Editorial: RNA Splicing and Backsplicing: Disease and Therapy. Front. Genet. 2020;11:626835. doi: 10.3389/fgene.2020.626835.</cite> [<a href="https://doi.org/10.3389/fgene.2020.626835" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7753067/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33363577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Genet.&amp;title=Editorial:%20RNA%20Splicing%20and%20Backsplicing:%20Disease%20and%20Therapy&amp;author=R.%20Asselta&amp;author=S.%20Duga&amp;author=E.A.%20Velasco&amp;author=E.%20Buratti&amp;volume=11&amp;publication_year=2020&amp;pages=626835&amp;pmid=33363577&amp;doi=10.3389/fgene.2020.626835&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-cancers-14-02960">
<span class="label">17.</span><cite>Tournier I., Vezain M., Martins A., Charbonnier F., Baert-Desurmont S., Olschwang S., Wang Q., Buisine M.P., Soret J., Tazi J., et al.  A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects. Hum. Mutat. 2008;29:1412–1424. doi: 10.1002/humu.20796.</cite> [<a href="https://doi.org/10.1002/humu.20796" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18561205/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=A%20large%20fraction%20of%20unclassified%20variants%20of%20the%20mismatch%20repair%20genes%20MLH1%20and%20MSH2%20is%20associated%20with%20splicing%20defects&amp;author=I.%20Tournier&amp;author=M.%20Vezain&amp;author=A.%20Martins&amp;author=F.%20Charbonnier&amp;author=S.%20Baert-Desurmont&amp;volume=29&amp;publication_year=2008&amp;pages=1412-1424&amp;pmid=18561205&amp;doi=10.1002/humu.20796&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-cancers-14-02960">
<span class="label">18.</span><cite>Parsons M.T., Tudini E., Li H., Hahnen E., Wappenschmidt B., Feliubadaló L., Aalfs C.M., Agata S., Aittomäki K., Alducci E., et al.  Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification. Hum. Mutat. 2019;40:1557–1578. doi: 10.1002/humu.23818.</cite> [<a href="https://doi.org/10.1002/humu.23818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6772163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31131967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Large%20scale%20multifactorial%20likelihood%20quantitative%20analysis%20of%20BRCA1%20and%20BRCA2%20variants:%20An%20ENIGMA%20resource%20to%20support%20clinical%20variant%20classification&amp;author=M.T.%20Parsons&amp;author=E.%20Tudini&amp;author=H.%20Li&amp;author=E.%20Hahnen&amp;author=B.%20Wappenschmidt&amp;volume=40&amp;publication_year=2019&amp;pages=1557-1578&amp;pmid=31131967&amp;doi=10.1002/humu.23818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-cancers-14-02960">
<span class="label">19.</span><cite>Sanoguera-Miralles L., Valenzuela-Palomo A., Bueno-Martínez E., Llovet P., Díez-Gómez B., Caloca M.J., Pérez-Segura P., Fraile-Bethencourt E., Colmena M., Carvalho S., et al.  Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the RAD51C Gene. Cancers. 2020;12:3771.  doi: 10.3390/cancers12123771.</cite> [<a href="https://doi.org/10.3390/cancers12123771" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7765170/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33333735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Comprehensive%20Functional%20Characterization%20and%20Clinical%20Interpretation%20of%2020%20Splice-Site%20Variants%20of%20the%20RAD51C%20Gene&amp;author=L.%20Sanoguera-Miralles&amp;author=A.%20Valenzuela-Palomo&amp;author=E.%20Bueno-Mart%C3%ADnez&amp;author=P.%20Llovet&amp;author=B.%20D%C3%ADez-G%C3%B3mez&amp;volume=12&amp;publication_year=2020&amp;pages=3771&amp;pmid=33333735&amp;doi=10.3390/cancers12123771&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-cancers-14-02960">
<span class="label">20.</span><cite>Valenzuela-Palomo A., Bueno-Martínez E., Sanoguera-Miralles L., Lorca V., Fraile-Bethencourt E., Esteban-Sánchez A., Gómez-Barrero S., Carvalho S., Allen J., García-Álvarez A., et al.  Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants. J. Pathol. 2022;256:321–334. doi: 10.1002/path.5839.</cite> [<a href="https://doi.org/10.1002/path.5839" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9306493/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34846068/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pathol.&amp;title=Splicing%20predictions,%20minigene%20analyses,%20and%20ACMG-AMP%20clinical%20classification%20of%2042%20germline%20PALB2%20splice-site%20variants&amp;author=A.%20Valenzuela-Palomo&amp;author=E.%20Bueno-Mart%C3%ADnez&amp;author=L.%20Sanoguera-Miralles&amp;author=V.%20Lorca&amp;author=E.%20Fraile-Bethencourt&amp;volume=256&amp;publication_year=2022&amp;pages=321-334&amp;pmid=34846068&amp;doi=10.1002/path.5839&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-cancers-14-02960">
<span class="label">21.</span><cite>Yeo G., Burge C.B. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 2004;11:377–394. doi: 10.1089/1066527041410418.</cite> [<a href="https://doi.org/10.1089/1066527041410418" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15285897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Comput.%20Biol.&amp;title=Maximum%20entropy%20modeling%20of%20short%20sequence%20motifs%20with%20applications%20to%20RNA%20splicing%20signals&amp;author=G.%20Yeo&amp;author=C.B.%20Burge&amp;volume=11&amp;publication_year=2004&amp;pages=377-394&amp;pmid=15285897&amp;doi=10.1089/1066527041410418&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22-cancers-14-02960">
<span class="label">22.</span><cite>Jaganathan K., Kyriazopoulou Panagiotopoulou S., McRae J.F., Darbandi S.F., Knowles D., Li Y.I., Kosmicki J.A., Arbelaez J., Cui W., Schwartz G.B., et al.  Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019;176:535–548.e24. doi: 10.1016/j.cell.2018.12.015.</cite> [<a href="https://doi.org/10.1016/j.cell.2018.12.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30661751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Predicting%20Splicing%20from%20Primary%20Sequence%20with%20Deep%20Learning&amp;author=K.%20Jaganathan&amp;author=S.%20Kyriazopoulou%20Panagiotopoulou&amp;author=J.F.%20McRae&amp;author=S.F.%20Darbandi&amp;author=D.%20Knowles&amp;volume=176&amp;publication_year=2019&amp;pages=535-548.e24&amp;pmid=30661751&amp;doi=10.1016/j.cell.2018.12.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23-cancers-14-02960">
<span class="label">23.</span><cite>de Garibay G.R., Acedo A., García-Casado Z., Gutiérrez-Enríquez S., Tosar A., Romero A., Garre P., Llort G., Thomassen M., Díez O., et al.  Capillary Electrophoresis Analysis of Conventional Splicing Assays: IARC Analytical and Clinical Classification of 31 BRCA2 Genetic Variants. Hum. Mutat. 2014;35:53–57. doi: 10.1002/humu.22456.</cite> [<a href="https://doi.org/10.1002/humu.22456" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24123850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Capillary%20Electrophoresis%20Analysis%20of%20Conventional%20Splicing%20Assays:%20IARC%20Analytical%20and%20Clinical%20Classification%20of%2031%20BRCA2%20Genetic%20Variants&amp;author=G.R.%20de%20Garibay&amp;author=A.%20Acedo&amp;author=Z.%20Garc%C3%ADa-Casado&amp;author=S.%20Guti%C3%A9rrez-Enr%C3%ADquez&amp;author=A.%20Tosar&amp;volume=35&amp;publication_year=2014&amp;pages=53-57&amp;pmid=24123850&amp;doi=10.1002/humu.22456&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24-cancers-14-02960">
<span class="label">24.</span><cite>Acedo A., Hernández-Moro C., Curiel-García Á., Díez-Gómez B., Velasco E.A. Functional classification of BRCA2 DNA variants by splicing assays in a large minigene with 9 exons. Hum. Mutat. 2015;36:210–221. doi: 10.1002/humu.22725.</cite> [<a href="https://doi.org/10.1002/humu.22725" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4371643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25382762/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Functional%20classification%20of%20BRCA2%20DNA%20variants%20by%20splicing%20assays%20in%20a%20large%20minigene%20with%209%20exons&amp;author=A.%20Acedo&amp;author=C.%20Hern%C3%A1ndez-Moro&amp;author=%C3%81.%20Curiel-Garc%C3%ADa&amp;author=B.%20D%C3%ADez-G%C3%B3mez&amp;author=E.A.%20Velasco&amp;volume=36&amp;publication_year=2015&amp;pages=210-221&amp;pmid=25382762&amp;doi=10.1002/humu.22725&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25-cancers-14-02960">
<span class="label">25.</span><cite>Bueno-Martínez E., Sanoguera-Miralles L., Valenzuela-Palomo A., Lorca V., Gómez-Sanz A., Carvalho S., Allen J., Infante M., Pérez-Segura P., Lázaro C., et al.  Rad51d aberrant splicing in breast cancer: Identification of splicing regulatory elements and minigene-based evaluation of 53 dna variants. Cancers. 2021;13:2845.  doi: 10.3390/cancers13112845.</cite> [<a href="https://doi.org/10.3390/cancers13112845" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8201001/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34200360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Rad51d%20aberrant%20splicing%20in%20breast%20cancer:%20Identification%20of%20splicing%20regulatory%20elements%20and%20minigene-based%20evaluation%20of%2053%20dna%20variants&amp;author=E.%20Bueno-Mart%C3%ADnez&amp;author=L.%20Sanoguera-Miralles&amp;author=A.%20Valenzuela-Palomo&amp;author=V.%20Lorca&amp;author=A.%20G%C3%B3mez-Sanz&amp;volume=13&amp;publication_year=2021&amp;pages=2845&amp;pmid=34200360&amp;doi=10.3390/cancers13112845&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26-cancers-14-02960">
<span class="label">26.</span><cite>Fraile-Bethencourt E., Díez-Gómez B., Velásquez-Zapata V., Acedo A., Sanz D.J., Velasco E.A. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18. PLoS Genet. 2017;13:e1006691.  doi: 10.1371/journal.pgen.1006691.</cite> [<a href="https://doi.org/10.1371/journal.pgen.1006691" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5384790/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28339459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genet.&amp;title=Functional%20classification%20of%20DNA%20variants%20by%20hybrid%20minigenes:%20Identification%20of%2030%20spliceogenic%20variants%20of%20BRCA2%20exons%2017%20and%2018&amp;author=E.%20Fraile-Bethencourt&amp;author=B.%20D%C3%ADez-G%C3%B3mez&amp;author=V.%20Vel%C3%A1squez-Zapata&amp;author=A.%20Acedo&amp;author=D.J.%20Sanz&amp;volume=13&amp;publication_year=2017&amp;pages=e1006691&amp;pmid=28339459&amp;doi=10.1371/journal.pgen.1006691&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27-cancers-14-02960">
<span class="label">27.</span><cite>Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al.  Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405–424. doi: 10.1038/gim.2015.30.</cite> [<a href="https://doi.org/10.1038/gim.2015.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4544753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25741868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Standards%20and%20guidelines%20for%20the%20interpretation%20of%20sequence%20variants:%20A%20joint%20consensus%20recommendation%20of%20the%20American%20College%20of%20Medical%20Genetics%20and%20Genomics%20and%20the%20Association%20for%20Molecular%20Pathology&amp;author=S.%20Richards&amp;author=N.%20Aziz&amp;author=S.%20Bale&amp;author=D.%20Bick&amp;author=S.%20Das&amp;volume=17&amp;publication_year=2015&amp;pages=405-424&amp;pmid=25741868&amp;doi=10.1038/gim.2015.30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28-cancers-14-02960">
<span class="label">28.</span><cite>Tavtigian S.V., Greenblatt M.S., Harrison S.M., Nussbaum R.L., Prabhu S.A., Boucher K.M., Biesecker L.G. ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI) Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet. Med. 2018;20:1054–1060. doi: 10.1038/gim.2017.210.</cite> [<a href="https://doi.org/10.1038/gim.2017.210" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6336098/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29300386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=ClinGen%20Sequence%20Variant%20Interpretation%20Working%20Group%20(ClinGen%20SVI)%20Modeling%20the%20ACMG/AMP%20variant%20classification%20guidelines%20as%20a%20Bayesian%20classification%20framework&amp;author=S.V.%20Tavtigian&amp;author=M.S.%20Greenblatt&amp;author=S.M.%20Harrison&amp;author=R.L.%20Nussbaum&amp;author=S.A.%20Prabhu&amp;volume=20&amp;publication_year=2018&amp;pages=1054-1060&amp;pmid=29300386&amp;doi=10.1038/gim.2017.210&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29-cancers-14-02960">
<span class="label">29.</span><cite>Tavtigian S.V., Harrison S.M., Boucher K.M., Biesecker L.G. Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines. Hum. Mutat. 2020;41:1734–1737. doi: 10.1002/humu.24088.</cite> [<a href="https://doi.org/10.1002/humu.24088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8011844/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32720330/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Fitting%20a%20naturally%20scaled%20point%20system%20to%20the%20ACMG/AMP%20variant%20classification%20guidelines&amp;author=S.V.%20Tavtigian&amp;author=S.M.%20Harrison&amp;author=K.M.%20Boucher&amp;author=L.G.%20Biesecker&amp;volume=41&amp;publication_year=2020&amp;pages=1734-1737&amp;pmid=32720330&amp;doi=10.1002/humu.24088&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30-cancers-14-02960">
<span class="label">30.</span><cite>Bueno-Martínez E., Sanoguera-Miralles L., Valenzuela-Palomo A., Esteban-Sánchez A., Lorca V., Llinares-Burguet I., Allen J., García-Álvarez A., Pérez-Segura P., Durán M., et al.  Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants. J. Pathol. 2022.  
in press
.</cite> [<a href="https://doi.org/10.1002/path.5979" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9541484/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35716007/" class="usa-link">PubMed</a>]</li>
<li id="B31-cancers-14-02960">
<span class="label">31.</span><cite>Abou Tayoun A.N., Pesaran T., DiStefano M.T., Oza A., Rehm H.L., Biesecker L.G., Harrison S.M. ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI) Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion. Hum. Mutat. 2018;39:1517–1524. doi: 10.1002/humu.23626.</cite> [<a href="https://doi.org/10.1002/humu.23626" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6185798/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30192042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=ClinGen%20Sequence%20Variant%20Interpretation%20Working%20Group%20(ClinGen%20SVI)%20Recommendations%20for%20interpreting%20the%20loss%20of%20function%20PVS1%20ACMG/AMP%20variant%20criterion&amp;author=A.N.%20Abou%20Tayoun&amp;author=T.%20Pesaran&amp;author=M.T.%20DiStefano&amp;author=A.%20Oza&amp;author=H.L.%20Rehm&amp;volume=39&amp;publication_year=2018&amp;pages=1517-1524&amp;pmid=30192042&amp;doi=10.1002/humu.23626&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32-cancers-14-02960">
<span class="label">32.</span><cite>French C.A., Tambini C.E., Thacker J. Identification of Functional Domains in the RAD51L2 (RAD51C) Protein and Its Requirement for Gene Conversion. J. Biol. Chem. 2003;278:45445–45450. doi: 10.1074/jbc.M308621200.</cite> [<a href="https://doi.org/10.1074/jbc.M308621200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12966089/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Identification%20of%20Functional%20Domains%20in%20the%20RAD51L2%20(RAD51C)%20Protein%20and%20Its%20Requirement%20for%20Gene%20Conversion&amp;author=C.A.%20French&amp;author=C.E.%20Tambini&amp;author=J.%20Thacker&amp;volume=278&amp;publication_year=2003&amp;pages=45445-45450&amp;pmid=12966089&amp;doi=10.1074/jbc.M308621200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33-cancers-14-02960">
<span class="label">33.</span><cite>Miller K.A., Sawicka D., Barsky D., Albala J.S. Domain mapping of the Rad51 paralog protein complexes. Nucleic Acids Res. 2004;32:169–178. doi: 10.1093/nar/gkg925.</cite> [<a href="https://doi.org/10.1093/nar/gkg925" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC373258/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14704354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=Domain%20mapping%20of%20the%20Rad51%20paralog%20protein%20complexes&amp;author=K.A.%20Miller&amp;author=D.%20Sawicka&amp;author=D.%20Barsky&amp;author=J.S.%20Albala&amp;volume=32&amp;publication_year=2004&amp;pages=169-178&amp;pmid=14704354&amp;doi=10.1093/nar/gkg925&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34-cancers-14-02960">
<span class="label">34.</span><cite>Gayarre J., Martín-Gimeno P., Osorio A., Paumard B., Barroso A., Fernández V., De La Hoya M., Rojo A., Caldés T., Palacios J., et al.  Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes. Br. J. Cancer. 2017;117:1048–1062. doi: 10.1038/bjc.2017.286.</cite> [<a href="https://doi.org/10.1038/bjc.2017.286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5625680/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28829762/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Cancer&amp;title=Characterisation%20of%20the%20novel%20deleterious%20RAD51C%20p.Arg312Trp%20variant%20and%20prioritisation%20criteria%20for%20functional%20analysis%20of%20RAD51C%20missense%20changes&amp;author=J.%20Gayarre&amp;author=P.%20Mart%C3%ADn-Gimeno&amp;author=A.%20Osorio&amp;author=B.%20Paumard&amp;author=A.%20Barroso&amp;volume=117&amp;publication_year=2017&amp;pages=1048-1062&amp;pmid=28829762&amp;doi=10.1038/bjc.2017.286&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35-cancers-14-02960">
<span class="label">35.</span><cite>Brandão R.D., Mensaert K., López-Perolio I., Tserpelis D., Xenakis M., Lattimore V., Walker L.C., Kvist A., Vega A., Gutiérrez-Enríquez S., et al.  Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes. Int. J. Cancer. 2019;145:401–414. doi: 10.1002/ijc.32114.</cite> [<a href="https://doi.org/10.1002/ijc.32114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6635756/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30623411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Cancer&amp;title=Targeted%20RNA-seq%20successfully%20identifies%20normal%20and%20pathogenic%20splicing%20events%20in%20breast/ovarian%20cancer%20susceptibility%20and%20Lynch%20syndrome%20genes&amp;author=R.D.%20Brand%C3%A3o&amp;author=K.%20Mensaert&amp;author=I.%20L%C3%B3pez-Perolio&amp;author=D.%20Tserpelis&amp;author=M.%20Xenakis&amp;volume=145&amp;publication_year=2019&amp;pages=401-414&amp;pmid=30623411&amp;doi=10.1002/ijc.32114&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36-cancers-14-02960">
<span class="label">36.</span><cite>Ioannidis N.M., Rothstein J.H., Pejaver V., Middha S., McDonnell S.K., Baheti S., Musolf A., Li Q., Holzinger E., Karyadi D., et al.  REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am. J. Hum. Genet. 2016;99:877–885. doi: 10.1016/j.ajhg.2016.08.016.</cite> [<a href="https://doi.org/10.1016/j.ajhg.2016.08.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5065685/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27666373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=REVEL:%20An%20Ensemble%20Method%20for%20Predicting%20the%20Pathogenicity%20of%20Rare%20Missense%20Variants&amp;author=N.M.%20Ioannidis&amp;author=J.H.%20Rothstein&amp;author=V.%20Pejaver&amp;author=S.%20Middha&amp;author=S.K.%20McDonnell&amp;volume=99&amp;publication_year=2016&amp;pages=877-885&amp;pmid=27666373&amp;doi=10.1016/j.ajhg.2016.08.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37-cancers-14-02960">
<span class="label">37.</span><cite>Nalepa G., Clapp D.W. Fanconi anaemia and cancer: An intricate relationship. Nat. Rev. Cancer. 2018;18:168–185. doi: 10.1038/nrc.2017.116.</cite> [<a href="https://doi.org/10.1038/nrc.2017.116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29376519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Cancer&amp;title=Fanconi%20anaemia%20and%20cancer:%20An%20intricate%20relationship&amp;author=G.%20Nalepa&amp;author=D.W.%20Clapp&amp;volume=18&amp;publication_year=2018&amp;pages=168-185&amp;pmid=29376519&amp;doi=10.1038/nrc.2017.116&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38-cancers-14-02960">
<span class="label">38.</span><cite>Makhnoon S., Shirts B.H., Bowen D.J. Patients’ perspectives of variants of uncertain significance and strategies for uncertainty management. J. Genet. Couns. 2019;28:313–325. doi: 10.1002/jgc4.1075.</cite> [<a href="https://doi.org/10.1002/jgc4.1075" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30636062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Genet.%20Couns.&amp;title=Patients%E2%80%99%20perspectives%20of%20variants%20of%20uncertain%20significance%20and%20strategies%20for%20uncertainty%20management&amp;author=S.%20Makhnoon&amp;author=B.H.%20Shirts&amp;author=D.J.%20Bowen&amp;volume=28&amp;publication_year=2019&amp;pages=313-325&amp;pmid=30636062&amp;doi=10.1002/jgc4.1075&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39-cancers-14-02960">
<span class="label">39.</span><cite>Truty R., Ouyang K., Rojahn S., Garcia S., Colavin A., Hamlington B., Freivogel M., Nussbaum R.L., Nykamp K., Aradhya S. Spectrum of splicing variants in disease genes and the ability of RNA analysis to reduce uncertainty in clinical interpretation. Am. J. Hum. Genet. 2021;108:696. doi: 10.1016/j.ajhg.2021.03.006.</cite> [<a href="https://doi.org/10.1016/j.ajhg.2021.03.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8059334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33743207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=Spectrum%20of%20splicing%20variants%20in%20disease%20genes%20and%20the%20ability%20of%20RNA%20analysis%20to%20reduce%20uncertainty%20in%20clinical%20interpretation&amp;author=R.%20Truty&amp;author=K.%20Ouyang&amp;author=S.%20Rojahn&amp;author=S.%20Garcia&amp;author=A.%20Colavin&amp;volume=108&amp;publication_year=2021&amp;pages=696&amp;pmid=33743207&amp;doi=10.1016/j.ajhg.2021.03.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40-cancers-14-02960">
<span class="label">40.</span><cite>Nix P., Mundt E., Coffee B., Goossen E., Warf B.M., Brown K., Bowles K., Roa B. Interpretation of BRCA2 Splicing Variants: A Case Series of Challenging Variant Interpretations and the Importance of Functional RNA Analysis. Fam. Cancer. 2021;1:7–19. doi: 10.1007/s10689-020-00224-y.</cite> [<a href="https://doi.org/10.1007/s10689-020-00224-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8799590/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33469799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fam.%20Cancer&amp;title=Interpretation%20of%20BRCA2%20Splicing%20Variants:%20A%20Case%20Series%20of%20Challenging%20Variant%20Interpretations%20and%20the%20Importance%20of%20Functional%20RNA%20Analysis&amp;author=P.%20Nix&amp;author=E.%20Mundt&amp;author=B.%20Coffee&amp;author=E.%20Goossen&amp;author=B.M.%20Warf&amp;volume=1&amp;publication_year=2021&amp;pages=7-19&amp;pmid=33469799&amp;doi=10.1007/s10689-020-00224-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41-cancers-14-02960">
<span class="label">41.</span><cite>Ma S.L., Vega-Warner V., Gillies C., Sampson M.G., Kher V., Sethi S.K., Otto E.A. Whole Exome Sequencing Reveals Novel PHEX Splice Site Mutations in Patients with Hypophosphatemic Rickets. PLoS ONE. 2015;10:e0130729.  doi: 10.1371/journal.pone.0130729.</cite> [<a href="https://doi.org/10.1371/journal.pone.0130729" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4479593/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26107949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Whole%20Exome%20Sequencing%20Reveals%20Novel%20PHEX%20Splice%20Site%20Mutations%20in%20Patients%20with%20Hypophosphatemic%20Rickets&amp;author=S.L.%20Ma&amp;author=V.%20Vega-Warner&amp;author=C.%20Gillies&amp;author=M.G.%20Sampson&amp;author=V.%20Kher&amp;volume=10&amp;publication_year=2015&amp;pages=e0130729&amp;pmid=26107949&amp;doi=10.1371/journal.pone.0130729&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42-cancers-14-02960">
<span class="label">42.</span><cite>Acedo A., Sanz D.J., Durán M., Infante M., Pérez-Cabornero L., Miner C., Velasco E.A. Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenes. Breast Cancer Res. 2012;14:R87. doi: 10.1186/bcr3202.</cite> [<a href="https://doi.org/10.1186/bcr3202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3446350/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22632462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.&amp;title=Comprehensive%20splicing%20functional%20analysis%20of%20DNA%20variants%20of%20the%20BRCA2%20gene%20by%20hybrid%20minigenes&amp;author=A.%20Acedo&amp;author=D.J.%20Sanz&amp;author=M.%20Dur%C3%A1n&amp;author=M.%20Infante&amp;author=L.%20P%C3%A9rez-Cabornero&amp;volume=14&amp;publication_year=2012&amp;pages=R87&amp;pmid=22632462&amp;doi=10.1186/bcr3202&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43-cancers-14-02960">
<span class="label">43.</span><cite>Fraile-Bethencourt E., Valenzuela-Palomo A., Díez-Gómez B., Caloca M.J., Gómez-Barrero S., Velasco E.A. Minigene Splicing Assays Identify 12 Spliceogenic Variants of BRCA2 Exons 14 and 15. Front. Genet. 2019;10:503. doi: 10.3389/fgene.2019.00503.</cite> [<a href="https://doi.org/10.3389/fgene.2019.00503" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6546720/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31191615/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Genet.&amp;title=Minigene%20Splicing%20Assays%20Identify%2012%20Spliceogenic%20Variants%20of%20BRCA2%20Exons%2014%20and%2015&amp;author=E.%20Fraile-Bethencourt&amp;author=A.%20Valenzuela-Palomo&amp;author=B.%20D%C3%ADez-G%C3%B3mez&amp;author=M.J.%20Caloca&amp;author=S.%20G%C3%B3mez-Barrero&amp;volume=10&amp;publication_year=2019&amp;pages=503&amp;pmid=31191615&amp;doi=10.3389/fgene.2019.00503&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44-cancers-14-02960">
<span class="label">44.</span><cite>Fraile-Bethencourt E., Valenzuela-Palomo A., Díez-Gómez B., Goina E., Acedo A., Buratti E., Velasco E.A. Mis-splicing in breast cancer: Identification of pathogenic BRCA2 variants by systematic minigene assays. J. Pathol. 2019;248:409–420. doi: 10.1002/path.5268.</cite> [<a href="https://doi.org/10.1002/path.5268" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30883759/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pathol.&amp;title=Mis-splicing%20in%20breast%20cancer:%20Identification%20of%20pathogenic%20BRCA2%20variants%20by%20systematic%20minigene%20assays&amp;author=E.%20Fraile-Bethencourt&amp;author=A.%20Valenzuela-Palomo&amp;author=B.%20D%C3%ADez-G%C3%B3mez&amp;author=E.%20Goina&amp;author=A.%20Acedo&amp;volume=248&amp;publication_year=2019&amp;pages=409-420&amp;pmid=30883759&amp;doi=10.1002/path.5268&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45-cancers-14-02960">
<span class="label">45.</span><cite>Roca X., Olson A.J., Rao A.R., Enerly E., Kristensen V.N., Børresen-Dale A.-L., Andresen B.S., Krainer A.R., Sachidanandam R. Features of 5′-splice-site efficiency derived from disease-causing mutations and comparative genomics. Genome Res. 2008;18:77. doi: 10.1101/gr.6859308.</cite> [<a href="https://doi.org/10.1101/gr.6859308" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2134769/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18032726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Res.&amp;title=Features%20of%205%E2%80%B2-splice-site%20efficiency%20derived%20from%20disease-causing%20mutations%20and%20comparative%20genomics&amp;author=X.%20Roca&amp;author=A.J.%20Olson&amp;author=A.R.%20Rao&amp;author=E.%20Enerly&amp;author=V.N.%20Kristensen&amp;volume=18&amp;publication_year=2008&amp;pages=77&amp;pmid=18032726&amp;doi=10.1101/gr.6859308&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46-cancers-14-02960">
<span class="label">46.</span><cite>Madsen P.P., Kibæk M., Roca X., Sachidanandam R., Krainer A.R., Christensen E., Steiner R.D., Gibson K.M., Corydon T.J., Knudsen I., et al.  Short/branched-chain acyl-CoA dehydrogenase deficiency due to an IVS3+3A&gt;G mutation that causes exon skipping. Hum. Genet. 2005;118:680–690. doi: 10.1007/s00439-005-0070-4.</cite> [<a href="https://doi.org/10.1007/s00439-005-0070-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16317551/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Genet.&amp;title=Short/branched-chain%20acyl-CoA%20dehydrogenase%20deficiency%20due%20to%20an%20IVS3+3A&gt;G%20mutation%20that%20causes%20exon%20skipping&amp;author=P.P.%20Madsen&amp;author=M.%20Kib%C3%A6k&amp;author=X.%20Roca&amp;author=R.%20Sachidanandam&amp;author=A.R.%20Krainer&amp;volume=118&amp;publication_year=2005&amp;pages=680-690&amp;pmid=16317551&amp;doi=10.1007/s00439-005-0070-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47-cancers-14-02960">
<span class="label">47.</span><cite>Parada G.E., Munita R., Cerda C.A., Gysling K. A comprehensive survey of non-canonical splice sites in the human transcriptome. Nucleic Acids Res. 2014;42:10564–10578. doi: 10.1093/nar/gku744.</cite> [<a href="https://doi.org/10.1093/nar/gku744" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4176328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25123659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=A%20comprehensive%20survey%20of%20non-canonical%20splice%20sites%20in%20the%20human%20transcriptome&amp;author=G.E.%20Parada&amp;author=R.%20Munita&amp;author=C.A.%20Cerda&amp;author=K.%20Gysling&amp;volume=42&amp;publication_year=2014&amp;pages=10564-10578&amp;pmid=25123659&amp;doi=10.1093/nar/gku744&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48-cancers-14-02960">
<span class="label">48.</span><cite>Lin J.-H., Tang X.-Y., Boulling A., Zou W.-B., Masson E., Fichou Y., Raud L., Le Tertre M., Deng S.-J., Berlivet I., et al.  First estimate of the scale of canonical 5′ splice site GT &gt; GC variants capable of generating wild-type transcripts. Hum. Mutat. 2019;40:1856–1873. doi: 10.1002/humu.23821.</cite> [<a href="https://doi.org/10.1002/humu.23821" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31131953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=First%20estimate%20of%20the%20scale%20of%20canonical%205%E2%80%B2%20splice%20site%20GT%20&gt;%20GC%20variants%20capable%20of%20generating%20wild-type%20transcripts&amp;author=J.-H.%20Lin&amp;author=X.-Y.%20Tang&amp;author=A.%20Boulling&amp;author=W.-B.%20Zou&amp;author=E.%20Masson&amp;volume=40&amp;publication_year=2019&amp;pages=1856-1873&amp;pmid=31131953&amp;doi=10.1002/humu.23821&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9221245/bin/cancers-14-02960-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (3.3MB, zip) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All sequencing and fragment analysis data are available at <a href="http://hdl.handle.net/10261/270934" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://hdl.handle.net/10261/270934</a>; <a href="https://doi.org/10.20350/digitalCSIC/14662" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.20350/digitalCSIC/14662</a>, accessed on 15 June 2022.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cancers are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/cancers14122960"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/cancers-14-02960.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9221245/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9221245/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9221245%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9221245/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9221245/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9221245/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/35740625/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9221245/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/35740625/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9221245/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9221245/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="EflYwQDcre4NJL9D5ydMj9zyxycfJNdIgpLbiI6KIWy7UREElxBmQhseEqBsMyId">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
